Article(id=1195386782205391084, tenantId=1146029695717560320, journalId=1190317699101192196, issueId=1195386781278449897, articleNumber=1001-2494(2024)01-0067-11, orderNo=null, doi=10.11669/cpj.2024.01.009, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=research-article, receivedDate=1688486400000, receivedDateStr=2023-07-05, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1762932018089, onlineDateStr=2025-11-12, pubDate=1704643200000, pubDateStr=2024-01-08, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1762932018089, onlineIssueDateStr=2025-11-12, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1762932018089, creator=13701087609, updateTime=1762932018089, updator=13701087609, issue=Issue{id=1195386781278449897, tenantId=1146029695717560320, journalId=1190317699101192196, year='2024', volume='59', issue='1', pageStart='1', pageEnd='96', issueExtLink='null', onlineDate='null', pubDate='null', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1762932017868, creator=13701087609, updateTime=1762998488032, updator=13701087609, preIssue=null, nextIssue=null, ext={EN=IssueExt(id=1195665577399333609, tenantId=1146029695717560320, journalId=1190317699101192196, issueId=1195386781278449897, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1195665577399333610, tenantId=1146029695717560320, journalId=1190317699101192196, issueId=1195386781278449897, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null}, startPage=67, endPage=77, ext={EN=ArticleExt(id=1195386782561906929, articleId=1195386782205391084, tenantId=1146029695717560320, journalId=1190317699101192196, language=EN, title=Determination of Related Substances in Gefitinib Raw Materials and Tablets, columnId=null, journalTitle=Chinese Pharmaceutical Journal, columnName=null, runingTitle=null, highlight=null, articleAbstract=
OBJECTIVE To establish a method for the determination of related substances in gefitinib and gefitinib tablets, evaluate the quality evaluation of products from different manufacturing enterprise and reserve methods for the new version of the Chinese Pharmacopoeia. METHODS HPLC experiment was performed on a column of CAPCELL PAK C18 MGⅡ (4.6 mm×250 mm,5 μm) with the mobile phase of 1% ammonium acetate solution (adjust pH to 6.20±0.05 with glacial acetic acid) (A)-acetonitrile (B) with gradient elution. The flow rate was 1.0 mL·min-1, the column temperature was maintained at 30 ℃, and the detection wavelength was set at 247 nm. The injection volume was 20 μL. RESULTS Gefitinib and 17 impurities showed good linear relationships with the peak area in the range between the LOQs and 0.2% of the principal component (r>0.999 0). The recoveries are between 89.4% and 108.6%. The LOQs are between 0.5 ng and 4.6 ng (equivalent to 0.002% to 0.02% of the principal component), and the LODs are between 0.1 ng and 1.0 ng (equivalent to 0.001% to 0.005% of the principal component). The results showed that the main impurity detected in gefitinib raw material was impurity B, while the main impurities detected in gefitinib tablets were impurity B and impurity Ⅴ. CONCLUSION This method is efficient, sensitive, accurate, and has good durability. It can be used for the quality control of impurities in gefitinib and gefitinib tablets. And it provides a reliable method for updating national pharmacopoeia standards.
, correspAuthors=LE Jian, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, authorCompany=null, fund=null, authors=null, authorsList=QIAN Min, SONG Dongmei, LE Jian), CN=ArticleExt(id=1195386888296116677, articleId=1195386782205391084, tenantId=1146029695717560320, journalId=1190317699101192196, language=CN, title=吉非替尼原料与片剂中有关物质测定方法研究, columnId=1190352405612040510, journalTitle=中国药学杂志, columnName=论著, runingTitle=null, highlight=null, articleAbstract=
目的 建立吉非替尼与吉非替尼片中有关物质的测定方法,用于评价各企业产品的质量,为本品种收录于新版《中国药典》提供方法储备。方法 采用CAPCELL PAK C18 MGⅡ色谱柱(4.6 mm×250 mm,5 μm),以10 g·L-1乙酸铵溶液(用冰乙酸调节pH值至6.20±0.05)(A)-乙腈(B)为流动相,梯度洗脱,流速为1.0 mL·min-1,柱温30 ℃;检测波长为247 nm,进样体积10 μL。结果 吉非替尼与17个杂质的浓度在各自定量限至相当于主成分的0.2%的范围内,与峰面积呈良好线性关系(r均大于0.999 0),回收率介于89.4%~108.6%之间,定量限介于0.5~4.6 ng之间(相当于主成分的0.002%~0.02%),检测限介于0.1~1.0 ng之间(相当于主成分的0.001%~0.005%),吉非替尼原料中检出主要杂质为杂质B,吉非替尼片中检出主要杂质为杂质B与杂质Ⅴ。结论 该方法高效、灵敏、准确,耐用性良好,可用于吉非替尼和吉非替尼片中杂质的质量控制,为国家药典标准增订提供了可靠的方法。
, correspAuthors=乐健, authorNote=null, correspAuthorsNote=
*乐健,男,主任药师 研究方向:药品质量控制与研究 Tel:(021)50798193
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=hvVNb6drwUimKb8imW3GMw==, magXml=tHPrtIxkWe/PeIhobMe3Cw==, pdfUrl=null, pdf=uf0W83+lJS3rgl+MgNbkOQ==, pdfFileSize=1571780, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=rHvRjKDzFLvpwchnF4IopQ==, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=U1F7PpgyLGMp1cSlJbqwaA==, mapNumber=null, authorCompany=null, fund=null, authors=
钱敏,女,副主任药师 研究方向:化学药品与药用辅料的质量标准研究
, authorsList=钱敏, 宋冬梅, 乐健)}, authors=[Author(id=1195498452755988909, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1195498452844069296, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, authorId=1195498452755988909, language=EN, stringName=QIAN Min, firstName=QIAN, middleName=null, lastName=Min, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=NMPA Key Laboratory for Quality Analysis of Chemical Drug Preparations, Shanghai Institute for Food and Drug Control, Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1195498452915372465, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, authorId=1195498452755988909, language=CN, stringName=钱敏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海市食品药品检验研究院, 国家药品监督管理局化学药品制剂质量分析重点实验室, 上海 201203, bio={"content":"
钱敏,女,副主任药师 研究方向:化学药品与药用辅料的质量标准研究
"}, bioImg=null, bioContent=
钱敏,女,副主任药师 研究方向:化学药品与药用辅料的质量标准研究
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1195498452676297129, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, xref=null, ext=[AuthorCompanyExt(id=1195498452684685738, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, companyId=1195498452676297129, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=NMPA Key Laboratory for Quality Analysis of Chemical Drug Preparations, Shanghai Institute for Food and Drug Control, Shanghai 201203, China), AuthorCompanyExt(id=1195498452697268651, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, companyId=1195498452676297129, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海市食品药品检验研究院, 国家药品监督管理局化学药品制剂质量分析重点实验室, 上海 201203)])]), Author(id=1195498452995064243, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1195498453074756021, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, authorId=1195498452995064243, language=EN, stringName=SONG Dongmei, firstName=SONG, middleName=null, lastName=Dongmei, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=NMPA Key Laboratory for Quality Analysis of Chemical Drug Preparations, Shanghai Institute for Food and Drug Control, Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1195498453183807926, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, authorId=1195498452995064243, language=CN, stringName=宋冬梅, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海市食品药品检验研究院, 国家药品监督管理局化学药品制剂质量分析重点实验室, 上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1195498452676297129, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, xref=null, ext=[AuthorCompanyExt(id=1195498452684685738, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, companyId=1195498452676297129, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=NMPA Key Laboratory for Quality Analysis of Chemical Drug Preparations, Shanghai Institute for Food and Drug Control, Shanghai 201203, China), AuthorCompanyExt(id=1195498452697268651, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, companyId=1195498452676297129, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海市食品药品检验研究院, 国家药品监督管理局化学药品制剂质量分析重点实验室, 上海 201203)])]), Author(id=1195498453271888312, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1195498453347385786, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, authorId=1195498453271888312, language=EN, stringName=LE Jian, firstName=LE, middleName=null, lastName=Jian, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=NMPA Key Laboratory for Quality Analysis of Chemical Drug Preparations, Shanghai Institute for Food and Drug Control, Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1195498453410300347, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, authorId=1195498453271888312, language=CN, stringName=乐健, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=上海市食品药品检验研究院, 国家药品监督管理局化学药品制剂质量分析重点实验室, 上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1195498452676297129, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, xref=null, ext=[AuthorCompanyExt(id=1195498452684685738, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, companyId=1195498452676297129, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=NMPA Key Laboratory for Quality Analysis of Chemical Drug Preparations, Shanghai Institute for Food and Drug Control, Shanghai 201203, China), AuthorCompanyExt(id=1195498452697268651, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, companyId=1195498452676297129, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海市食品药品检验研究院, 国家药品监督管理局化学药品制剂质量分析重点实验室, 上海 201203)])])], keywords=[Keyword(id=1195498453544518076, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, orderNo=1, keyword=gefitinib), Keyword(id=1195498453624209853, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, orderNo=2, keyword=related substance), Keyword(id=1195498453687124414, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, orderNo=3, keyword=content determination), Keyword(id=1195498453741650367, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, orderNo=4, keyword=quality control), Keyword(id=1195498453804564928, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, orderNo=1, keyword=吉非替尼), Keyword(id=1195498453871673793, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, orderNo=2, keyword=有关物质), Keyword(id=1195498453934588354, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, orderNo=3, keyword=测定), Keyword(id=1195498454010085827, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, orderNo=4, keyword=质量控制)], refs=[Reference(id=1195498457554272734, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, doi=null, pmid=null, pmcid=null, year=2002, volume=62, issue=20, pageStart=5749, pageEnd=5754, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=WAKELING A E, GUY S P, WOODBURN J R, journalName=Cancer Res, refType=null, unstructuredReference=
WAKELING A E,
GUY S P,
WOODBURN J R,
et al. ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy[J].
Cancer Res,
2002,
62 (20): 5749-5754., articleTitle=ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy, refAbstract=null), Reference(id=1195498457608798687, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=GIBSON, KEITH, HOPKINSON, journalName=null, refType=null, unstructuredReference=GIBSON, KEITH, HOPKINSON,ZENECA Ltd. Quinazoline Derivatives: England, WO1996033980A1[P]. 1996-10-31., articleTitle=WO1996033980A1, refAbstract=null), Reference(id=1195498457684296160, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, doi=null, pmid=null, pmcid=null, year=2020, volume=null, issue=null, pageStart=2737, pageEnd=2738, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=EP 10.0, refType=null, unstructuredReference=
EP 10.0[S].
2020: 2737-2738., articleTitle=null, refAbstract=null), Reference(id=1195498457755599329, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=GILDAY J P, MOODY D, journalName=null, refType=null, unstructuredReference=
GILDAY J P,
MOODY D. Process for the preparation of 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy) quinazoline: England,WO2004024703[P]. 2004-03-25., articleTitle=Process for the preparation of 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy) quinazoline: England,WO2004024703, refAbstract=null), Reference(id=1195498457822708194, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=GILDAY J P, WELHAM M J, journalName=null, refType=null, unstructuredReference=
GILDAY J P,
WELHAM M J. Process for the manufacture of gefitinib: England, WO2005023783[P]. 2005-03-17., articleTitle=Process for the manufacture of gefitinib: England, WO2005023783, refAbstract=null), Reference(id=1195498457881428451, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, doi=null, pmid=null, pmcid=null, year=2013, volume=25, issue=8, pageStart=1180, pageEnd=1184, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=SUN J, LI J Y, ZHANG Q X, journalName=Chem Res, refType=null, unstructuredReference=
SUN J,
LI J Y,
ZHANG Q X,
et al. Study on synthetic method of antineoplastic gefitinib[J].
Chem Res (化学研究与应用),
2013,
25(8): 1180-1184., articleTitle=Study on synthetic method of antineoplastic gefitinib, refAbstract=null), Reference(id=1195498457961120228, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, doi=null, pmid=null, pmcid=null, year=2012, volume=47, issue=13, pageStart=1084, pageEnd=1087, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=CHEN R H, YE L B, YUAN P, journalName=Chin Pharm J, refType=null, unstructuredReference=
CHEN R H,
YE L B,
YUAN P. Improvment of the synthesis of gefitinib[J].
Chin Pharm J (中国药学杂志),
2012,
47(13): 1084-1087., articleTitle=Improvment of the synthesis of gefitinib, refAbstract=null), Reference(id=1195498458032423397, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, doi=null, pmid=null, pmcid=null, year=2017, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=GUO X J, journalName=Studies on the synthesis process and impurities of gefitinib, refType=null, unstructuredReference=
GUO X J.
Studies on the synthesis process and impurities of gefitinib[D]. Hangzhou: Zhejiang University,
2017., articleTitle=null, refAbstract=null), Reference(id=1195498458103726566, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, doi=null, pmid=null, pmcid=null, year=2018, volume=28, issue=4, pageStart=295, pageEnd=298, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=YU J, PENG P P, ZHANG M H, journalName=Chin J Med Chem, refType=null, unstructuredReference=
YU J,
PENG P P,
ZHANG M H,
et al. A novel synthetic approach of gefitinib[J].
Chin J Med Chem (中国药物化学杂志),
2018,
28(4): 295-298., articleTitle=A novel synthetic approach of gefitinib, refAbstract=null), Reference(id=1195498458208584167, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, doi=null, pmid=null, pmcid=null, year=2014, volume=52, issue=8, pageStart=799, pageEnd=805, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=CHANDRASHEKARA K A, UDUPI A, REDDY C G, journalName=J Chromatogr Sci, refType=null, unstructuredReference=
CHANDRASHEKARA K A,
UDUPI A,
REDDY C G. Separation and estimation of process-related impurities of gefitinib by reverse-phase high-performance liquid chromatography[J].
J Chromatogr Sci,
2014,
52(8): 799-805., articleTitle=Separation and estimation of process-related impurities of gefitinib by reverse-phase high-performance liquid chromatography, refAbstract=null), Reference(id=1195498458300858856, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, doi=null, pmid=null, pmcid=null, year=2016, volume=36, issue=4, pageStart=704, pageEnd=710, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=QI J J, SUN C Y, CHU Y F, journalName=Chin J Pharm Anal, refType=null, unstructuredReference=
QI J J,
SUN C Y,
CHU Y F,
et al. Determination of related substances of gefitinib by HPLC[J].
Chin J Pharm Anal (药物分析杂志),
2016,
36(4): 704-710., articleTitle=Determination of related substances of gefitinib by HPLC, refAbstract=null), Reference(id=1195498458359579113, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, doi=null, pmid=null, pmcid=null, year=2016, volume=35, issue=1, pageStart=35, pageEnd=41, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=WU X H, LUO A, YE L B, journalName=J Instrum Anal, refType=null, unstructuredReference=
WU X H,
LUO A,
YE L B,
et al. Simultaneous determination of gefitinib and its related substances in raw material drugs by reversed-phase high performance liquid chromatography[J].
J Instrum Anal (分析测试学报),
2016,
35(1): 35-41., articleTitle=Simultaneous determination of gefitinib and its related substances in raw material drugs by reversed-phase high performance liquid chromatography, refAbstract=null), Reference(id=1195498458418299370, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, doi=null, pmid=null, pmcid=null, year=2015, volume=26, issue=15, pageStart=2138, pageEnd=2141, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=LIANG X D, MA X T, HE L, journalName=J Chin Pharm, refType=null, unstructuredReference=
LIANG X D,
MA X T,
HE L,
et al. Determination of the content of gefitinib active pharmaceutical ingredients and related substances by HPLC[J].
J Chin Pharm (中国药房),
2015,
26(15): 2138-2141., articleTitle=Determination of the content of gefitinib active pharmaceutical ingredients and related substances by HPLC, refAbstract=null), Reference(id=1195498458485408235, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, doi=null, pmid=null, pmcid=null, year=2017, volume=15, issue=2, pageStart=217, pageEnd=220, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=SUN C Y, QI J J, SHI Y, journalName=Cent South Pharm, refType=null, unstructuredReference=
SUN C Y,
QI J J,
SHI Y. Determination of impurity X in gefitinib raw material by HPLC with HILIC column[J].
Cent South Pharm (中南药学),
2017,
15(2): 217-220., articleTitle=Determination of impurity X in gefitinib raw material by HPLC with HILIC column, refAbstract=null), Reference(id=1195498458569294316, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, doi=null, pmid=null, pmcid=null, year=2016, volume=31, issue=5, pageStart=526, pageEnd=528, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=YE L B, YANG J B, WU J, journalName=West China J Pharm Sci, refType=null, unstructuredReference=
YE L B,
YANG J B,
WU J,
et al. Determination of the related substances in gefitinib by HPLC[J].
West China J Pharm Sci (华西药学杂志),
2016,
31(5): 526-528., articleTitle=Determination of the related substances in gefitinib by HPLC, refAbstract=null)], funds=[Fund(id=1195498457315197404, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, awardId=2020H057, language=CN, fundingSource=国家药典委员会药品标准提高制修订研究课题资助(2020H057), fundOrder=null, country=null), Fund(id=1195498457382306269, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, awardId=2020H058, language=CN, fundingSource=国家药典委员会药品标准提高制修订研究课题资助(2020H058), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1195498452676297129, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, xref=null, ext=[AuthorCompanyExt(id=1195498452684685738, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, companyId=1195498452676297129, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=NMPA Key Laboratory for Quality Analysis of Chemical Drug Preparations, Shanghai Institute for Food and Drug Control, Shanghai 201203, China), AuthorCompanyExt(id=1195498452697268651, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, companyId=1195498452676297129, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海市食品药品检验研究院, 国家药品监督管理局化学药品制剂质量分析重点实验室, 上海 201203)])], figs=[ArticleFig(id=1195498454249161156, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, label=Fig.1, caption=
Structures of the impurities in gefinitib and gefitinib tablets, figureFileSmall=FWPkZFOi7jjOSAcjJ2yTdQ==, figureFileBig=a1fSkGXvzBX9knrNXa9nhw==, tableContent=null), ArticleFig(id=1195498454316270021, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, label=图1, caption=
吉非替尼原料和片剂中的杂质结构, figureFileSmall=FWPkZFOi7jjOSAcjJ2yTdQ==, figureFileBig=a1fSkGXvzBX9knrNXa9nhw==, tableContent=null), ArticleFig(id=1195498454408544710, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, label=Fig.2, caption=
Chromatograms of specific tests for gefitinib related substances A-system suitbility solution; B-placebo solution; C-gefitinib (Lot: 20181001); D-gefitinib tablet (Lot: 20181201).
, figureFileSmall=m2GEs2+BI0V3sr2AH1WYdw==, figureFileBig=IYEwCnYpfwftxR+1Lg7VPQ==, tableContent=null), ArticleFig(id=1195498454467264967, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, label=图2, caption=
吉非替尼有关物质测定专属性试验色谱图 A-系统适用性溶液;B-阴性溶液;C-吉非替尼(批号:20181001);D-吉非替尼片(批号:20181201)。
, figureFileSmall=m2GEs2+BI0V3sr2AH1WYdw==, figureFileBig=IYEwCnYpfwftxR+1Lg7VPQ==, tableContent=null), ArticleFig(id=1195498454534373832, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, label=Fig.3, caption=
Chromatograms of degradation tests for gefitinib related substances A-gefitinib(Lot: DA203M-4-181201); B-gefitinib(Lot: 606110231); C-gefitinib tablets(Lot: 2031190301); D-gefitinib tablets(Lot: 2004014); a-non degradation; b-acid degradation; c-base degradation; d-oxidative degradation; e-UV degradation; f-heat degradation; g-ultrasonic degradation.
, figureFileSmall=qdxuBNr3NnTYD8qniv30Ew==, figureFileBig=wtcT3MUKCQcIBoflYifFrw==, tableContent=null), ArticleFig(id=1195498454622454217, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, label=图3, caption=
吉非替尼有关物质测定强破坏试验色谱图 A-吉非替尼(批号:DA203M-4-181201);B-吉非替尼(批号:606110231);C-吉非替尼片(批号:2031190301);D-吉非替尼片(批号:2004014);a-未破坏;b-酸破坏;c-碱破坏;d-氧化破坏;e-紫外光照破坏;f-高温破坏;g-超声波破坏。
, figureFileSmall=qdxuBNr3NnTYD8qniv30Ew==, figureFileBig=wtcT3MUKCQcIBoflYifFrw==, tableContent=null), ArticleFig(id=1195498454681174474, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, label=Tab.1, caption=
Information of reference substances used in the study of gefitinib related substances
, figureFileSmall=null, figureFileBig=null, tableContent=
| Compound | Lot. | Purity/% |
| Gefitinib | 420019-201902 | 99.8 |
| Impurity A | 420045-201701 | 100 |
| Impurity Ⅲ | 20191428 | 96.5 |
| Impurity Ⅳ | GTFN-223-180901 | 99.8 |
| Impurity V | 9011461N1DYS | 99.5 |
| Impurity Ⅵ | XS120711-01 | 96.7 |
| Impurity Ⅶ | LS50U72 | 99.58 |
| Impurity Ⅷ | 2-0-GFNB-191 | 97.30 |
| Impurity Ⅸ | GTFN-227-180901 | 99.7 |
| Impurity Ⅹ | XS150206-01 | 97.9 |
| Impurity Ⅺ | 20190614 | 96.4 |
| Impurity Ⅻ | 562-3201 | 98.25 |
| Impurity B | 20190523-1 | 96.3 |
| Impurity ⅩⅢ | 20190617 | 96.3 |
| Impurity ⅩⅣ | XS120625-01 | 98.2 |
| Impurity ⅩⅤ | 200203-5D-C09 | 99.70 |
| Impurity ⅩⅥ | RRW757 | 96 |
| Impurity ⅩⅦ | 200301-8D-133 | 98.36 |
), ArticleFig(id=1195498455775887819, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, label=表1, caption=
吉非替尼有关物质研究所用对照品相关信息
, figureFileSmall=null, figureFileBig=null, tableContent=
| Compound | Lot. | Purity/% |
| Gefitinib | 420019-201902 | 99.8 |
| Impurity A | 420045-201701 | 100 |
| Impurity Ⅲ | 20191428 | 96.5 |
| Impurity Ⅳ | GTFN-223-180901 | 99.8 |
| Impurity V | 9011461N1DYS | 99.5 |
| Impurity Ⅵ | XS120711-01 | 96.7 |
| Impurity Ⅶ | LS50U72 | 99.58 |
| Impurity Ⅷ | 2-0-GFNB-191 | 97.30 |
| Impurity Ⅸ | GTFN-227-180901 | 99.7 |
| Impurity Ⅹ | XS150206-01 | 97.9 |
| Impurity Ⅺ | 20190614 | 96.4 |
| Impurity Ⅻ | 562-3201 | 98.25 |
| Impurity B | 20190523-1 | 96.3 |
| Impurity ⅩⅢ | 20190617 | 96.3 |
| Impurity ⅩⅣ | XS120625-01 | 98.2 |
| Impurity ⅩⅤ | 200203-5D-C09 | 99.70 |
| Impurity ⅩⅥ | RRW757 | 96 |
| Impurity ⅩⅦ | 200301-8D-133 | 98.36 |
), ArticleFig(id=1195498455863968204, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, label=Tab.2, caption=
LOQs and LODs of gefitinib and the impurities
, figureFileSmall=null, figureFileBig=null, tableContent=
| Compound | LOQ | LOD |
| m/ng | Percentage/% | m/ng | Percentage/% |
| Gefitinib | 0.61 | 0.003 | 0.12 | 0.001 |
| Impurity A | 0.88 | 0.004 | 0.20 | 0.001 |
| ImpurityⅢ | 0.93 | 0.005 | 0.24 | 0.001 |
| Impurity Ⅳ | 0.47 | 0.002 | 0.11 | 0.001 |
| Impurity Ⅴ | 0.91 | 0.005 | 0.22 | 0.001 |
| Impurity Ⅵ | 4.64 | 0.023 | 0.99 | 0.005 |
| Impurity Ⅶ | 2.51 | 0.013 | 0.58 | 0.003 |
| Impurity Ⅷ | 1.57 | 0.008 | 0.33 | 0.002 |
| Impurity Ⅸ | 1.08 | 0.005 | 0.20 | 0.001 |
| Impurity Ⅹ | 1.82 | 0.009 | 0.44 | 0.002 |
| Impurity Ⅺ | 3.77 | 0.019 | 0.99 | 0.005 |
| Impurity Ⅻ | 1.95 | 0.010 | 0.54 | 0.003 |
| Impurity B | 1.15 | 0.006 | 0.25 | 0.001 |
| Impurity ⅩⅢ | 1.07 | 0.005 | 0.24 | 0.001 |
| Impurity ⅩⅣ | 0.49 | 0.002 | 0.15 | 0.001 |
| Impurity ⅩⅤ | 1.08 | 0.005 | 0.33 | 0.002 |
| Impurity ⅩⅥ | 1.28 | 0.006 | 0.33 | 0.002 |
| Impurity ⅩⅦ | 2.65 | 0.013 | 0.60 | 0.003 |
), ArticleFig(id=1195498455943659981, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, label=表2, caption=
吉非替尼与各杂质的定量限与检测限
, figureFileSmall=null, figureFileBig=null, tableContent=
| Compound | LOQ | LOD |
| m/ng | Percentage/% | m/ng | Percentage/% |
| Gefitinib | 0.61 | 0.003 | 0.12 | 0.001 |
| Impurity A | 0.88 | 0.004 | 0.20 | 0.001 |
| ImpurityⅢ | 0.93 | 0.005 | 0.24 | 0.001 |
| Impurity Ⅳ | 0.47 | 0.002 | 0.11 | 0.001 |
| Impurity Ⅴ | 0.91 | 0.005 | 0.22 | 0.001 |
| Impurity Ⅵ | 4.64 | 0.023 | 0.99 | 0.005 |
| Impurity Ⅶ | 2.51 | 0.013 | 0.58 | 0.003 |
| Impurity Ⅷ | 1.57 | 0.008 | 0.33 | 0.002 |
| Impurity Ⅸ | 1.08 | 0.005 | 0.20 | 0.001 |
| Impurity Ⅹ | 1.82 | 0.009 | 0.44 | 0.002 |
| Impurity Ⅺ | 3.77 | 0.019 | 0.99 | 0.005 |
| Impurity Ⅻ | 1.95 | 0.010 | 0.54 | 0.003 |
| Impurity B | 1.15 | 0.006 | 0.25 | 0.001 |
| Impurity ⅩⅢ | 1.07 | 0.005 | 0.24 | 0.001 |
| Impurity ⅩⅣ | 0.49 | 0.002 | 0.15 | 0.001 |
| Impurity ⅩⅤ | 1.08 | 0.005 | 0.33 | 0.002 |
| Impurity ⅩⅥ | 1.28 | 0.006 | 0.33 | 0.002 |
| Impurity ⅩⅦ | 2.65 | 0.013 | 0.60 | 0.003 |
), ArticleFig(id=1195498456006574542, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, label=Tab.3, caption=
Linearity results and correction factors of Gefinitib and the impurities
, figureFileSmall=null, figureFileBig=null, tableContent=
| Compound | Concentration range/μg·mL-1 | Regression equations | r | Correction factors |
| Gefitinib | 0.115 0-4.598 8 | y=36.100x+11.405 | 0.999 2 | 1.0 |
| Impurity A | 0.062 5-4.168 0 | y=69.195x-3.265 | 0.999 7 | 0.52 |
| Impurity Ⅲ | 0.105 0-4.199 7 | y=28.425x-2.375 | 0.999 4 | 1.27 |
| Impurity Ⅳ | 0.041 3-4.127 7 | y=41.582x-1.512 | 0.999 7 | 0.87 |
| Impurity Ⅴ | 0.219 3 -4.386 0 | y=35.096x-1.621 | 0.999 8 | 1.03 |
| ImpurityⅥ | 0.427 0-4.270 3 | y=17.883x-2.013 | 0.999 5 | 2.02 |
| Impurity Ⅶ | 0.193 2-3.863 7 | y=27.188x-1.560 | 0.999 3 | 1.33 |
| Impurity Ⅷ | 0.211 3-4.226 7 | y=37.504x-1.718 | 0.999 2 | 0.96 |
| Impurity Ⅸ | 0.102 3-4.091 7 | y=67.656x-3.166 | 0.999 6 | 0.53 |
| Impurity Ⅹ | 0.414 3-4.143 1 | y=40.150x-2.747 | 0.999 8 | 0.90 |
| Impurity Ⅺ | 1.025 7-4.102 8 | y=20.447x-1.773 | 0.999 4 | 1.77 |
| Impurity Ⅻ | 0.421 3-4.213 0 | y=47.079x-6.089 | 0.999 1 | 0.77 |
| Impurity B | 0.102 7-4.106 2 | y=31.084x-1.300 | 0.999 6 | 1.16 |
| Impurity ⅩⅢ | 0.104 4-4.175 6 | y=34.750x-1.120 | 0.999 7 | 1.04 |
| Impurity ⅩⅣ | 0.107 0-4.281 5 | y=43.632x-1.051 | 0.999 8 | 0.83 |
| Impurity ⅩⅤ | 0.222 1-4.442 6 | y=27.209x-1.132 | 0.999 6 | 1.33 |
| Impurity ⅩⅥ | 0.210 4-4.208 6 | y=29.395x-0.492 | 0.999 8 | 1.23 |
| Impurity ⅩⅦ | 0.439 1-4.390 8 | y=17.389x-0.469 | 0.999 7 | 2.08 |
), ArticleFig(id=1195498456086266319, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, label=表3, caption=
吉非替尼与各杂质的线性考察结果与校正因子
, figureFileSmall=null, figureFileBig=null, tableContent=
| Compound | Concentration range/μg·mL-1 | Regression equations | r | Correction factors |
| Gefitinib | 0.115 0-4.598 8 | y=36.100x+11.405 | 0.999 2 | 1.0 |
| Impurity A | 0.062 5-4.168 0 | y=69.195x-3.265 | 0.999 7 | 0.52 |
| Impurity Ⅲ | 0.105 0-4.199 7 | y=28.425x-2.375 | 0.999 4 | 1.27 |
| Impurity Ⅳ | 0.041 3-4.127 7 | y=41.582x-1.512 | 0.999 7 | 0.87 |
| Impurity Ⅴ | 0.219 3 -4.386 0 | y=35.096x-1.621 | 0.999 8 | 1.03 |
| ImpurityⅥ | 0.427 0-4.270 3 | y=17.883x-2.013 | 0.999 5 | 2.02 |
| Impurity Ⅶ | 0.193 2-3.863 7 | y=27.188x-1.560 | 0.999 3 | 1.33 |
| Impurity Ⅷ | 0.211 3-4.226 7 | y=37.504x-1.718 | 0.999 2 | 0.96 |
| Impurity Ⅸ | 0.102 3-4.091 7 | y=67.656x-3.166 | 0.999 6 | 0.53 |
| Impurity Ⅹ | 0.414 3-4.143 1 | y=40.150x-2.747 | 0.999 8 | 0.90 |
| Impurity Ⅺ | 1.025 7-4.102 8 | y=20.447x-1.773 | 0.999 4 | 1.77 |
| Impurity Ⅻ | 0.421 3-4.213 0 | y=47.079x-6.089 | 0.999 1 | 0.77 |
| Impurity B | 0.102 7-4.106 2 | y=31.084x-1.300 | 0.999 6 | 1.16 |
| Impurity ⅩⅢ | 0.104 4-4.175 6 | y=34.750x-1.120 | 0.999 7 | 1.04 |
| Impurity ⅩⅣ | 0.107 0-4.281 5 | y=43.632x-1.051 | 0.999 8 | 0.83 |
| Impurity ⅩⅤ | 0.222 1-4.442 6 | y=27.209x-1.132 | 0.999 6 | 1.33 |
| Impurity ⅩⅥ | 0.210 4-4.208 6 | y=29.395x-0.492 | 0.999 8 | 1.23 |
| Impurity ⅩⅦ | 0.439 1-4.390 8 | y=17.389x-0.469 | 0.999 7 | 2.08 |
), ArticleFig(id=1195498456161763792, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, label=Tab.4, caption=
Precision results of gefinitib and the impurities
, figureFileSmall=null, figureFileBig=null, tableContent=
| Compound | LOQ RSD/% | 1 μg·mL-1 (0.05%) RSD/% | 2 μg·mL-1 (0.1%) RSD/% |
| Gefitinib | 1.3 | 0.32 | 1.3 |
| Impurity A | 1.3 | 0.53 | 0.02 |
| Impurity Ⅲ | 0.99 | 0.87 | 0.47 |
| Impurity Ⅳ | 0.55 | 0.28 | 0.22 |
| Impurity Ⅴ | 1.7 | 0.50 | 0.09 |
| Impurity Ⅵ | 0.67 | 1.34 | 0.34 |
| Impurity Ⅶ | 1.8 | 0.53 | 0.54 |
| Impurity Ⅷ | 2.0 | 0.96 | 0.87 |
| ImpurityⅨ | 1.7 | 0.41 | 0.17 |
| Impurity Ⅹ | 2.2 | 0.19 | 0.22 |
| Impurity Ⅺ | 1.6 | 0.92 | 0.27 |
| Impurity Ⅻ | 1.1 | 1.7 | 0.64 |
| Impurity B | 1.7 | 0.55 | 0.39 |
| Impurity ⅩⅢ | 2.2 | 1.2 | 0.54 |
| Impurity ⅩⅣ | 1.7 | 0.37 | 0.11 |
| Impurity ⅩⅤ | 2.0 | 0.67 | 0.35 |
| Impurity ⅩⅥ | 2.0 | 0.31 | 0.15 |
| Impurity ⅩⅦ | 1.1 | 0.83 | 1.1 |
), ArticleFig(id=1195498456245649873, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, label=表4, caption=
吉非替尼与各杂质进样精密度考察结果
, figureFileSmall=null, figureFileBig=null, tableContent=
| Compound | LOQ RSD/% | 1 μg·mL-1 (0.05%) RSD/% | 2 μg·mL-1 (0.1%) RSD/% |
| Gefitinib | 1.3 | 0.32 | 1.3 |
| Impurity A | 1.3 | 0.53 | 0.02 |
| Impurity Ⅲ | 0.99 | 0.87 | 0.47 |
| Impurity Ⅳ | 0.55 | 0.28 | 0.22 |
| Impurity Ⅴ | 1.7 | 0.50 | 0.09 |
| Impurity Ⅵ | 0.67 | 1.34 | 0.34 |
| Impurity Ⅶ | 1.8 | 0.53 | 0.54 |
| Impurity Ⅷ | 2.0 | 0.96 | 0.87 |
| ImpurityⅨ | 1.7 | 0.41 | 0.17 |
| Impurity Ⅹ | 2.2 | 0.19 | 0.22 |
| Impurity Ⅺ | 1.6 | 0.92 | 0.27 |
| Impurity Ⅻ | 1.1 | 1.7 | 0.64 |
| Impurity B | 1.7 | 0.55 | 0.39 |
| Impurity ⅩⅢ | 2.2 | 1.2 | 0.54 |
| Impurity ⅩⅣ | 1.7 | 0.37 | 0.11 |
| Impurity ⅩⅤ | 2.0 | 0.67 | 0.35 |
| Impurity ⅩⅥ | 2.0 | 0.31 | 0.15 |
| Impurity ⅩⅦ | 1.1 | 0.83 | 1.1 |
), ArticleFig(id=1195498456325341650, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, label=Tab.5, caption=
Recoveries of the impurities in gefitinib and gefitinib tablets
, figureFileSmall=null, figureFileBig=null, tableContent=
| Impurities | Gefitinib | Gefitinib tablets |
ρ(Added) /μg·mL-1 | ρ(Original) /μg·mL-1 | ρ(Measured) /μg·mL-1 | Recovery /% | Average /% | RSD /% | ρ(Original) /μg·mL-1 | ρ(Measured) /μg·mL-1 | Recovery /% | Average /% | RSD /% |
| Impurity A | 0.062 50 | 0 | 0.062 23 | 99.6 | 98.5 | 2.1 | 0 | 0.067 68 | 108.3 | 108.0 | 0.35 |
| 0.062 50 | 0 | 0.060 14 | 96.2 | | | 0 | 0.067 50 | 108.0 | | |
| 0.062 50 | 0 | 0.062 41 | 99.9 | | | 0 | 0.067 22 | 107.6 | | |
| 1.042 | 0 | 1.109 | 106.4 | 106.5 | 0.73 | 0 | 1.110 | 106.5 | 106.8 | 0.28 |
| 1.042 | 0 | 1.118 | 107.3 | | | 0 | 1.113 | 106.8 | | |
| 1.042 | 0 | 1.102 | 105.7 | | | 0 | 1.116 | 107.1 | | |
| 2.084 | 0 | 2.089 | 100.2 | 100.6 | 0.46 | 0 | 2.148 | 103.1 | 103.0 | 0.15 |
| 2.084 | 0 | 2.095 | 100.5 | | | 0 | 2.144 | 102.9 | | |
| 2.084 | 0 | 2.107 | 101.1 | | | 0 | 2.150 | 103.2 | | |
| Impurity Ⅲ | 0.105 0 | 0 | 0.102 5 | 97.6 | 94.5 | 5.3 | 0.043 46 | 0.103 2 | 56.9 | 57.2 | 1.29 |
| 0.105 0 | 0 | 0.102 1 | 97.3 | | | 0.043 46 | 0.104 4 | 58.0 | | |
| 0.105 0 | 0 | 0.093 2 | 88.7 | | | 0.043 46 | 0.102 9 | 56.7 | | |
| 1.050 | 0 | 0.938 6 | 89.4 | 89.4 | 0.93 | 0.043 46 | 0.645 4 | 57.4 | 56.8 | 0.86 |
| 1.050 | 0 | 0.947 4 | 90.2 | | | 0.043 46 | 0.636 5 | 56.5 | | |
| 1.050 | 0 | 0.929 9 | 88.6 | | | 0.043 46 | 0.636 6 | 56.5 | | |
| 2.100 | 0 | 1.896 | 90.3 | 90.6 | 0.57 | 0.043 46 | 1.264 | 58.2 | 56.0 | 4.8 |
| 2.100 | 0 | 1.915 | 91.2 | | | 0.043 46 | 1.235 | 56.9 | | |
| 2.100 | 0 | 1.896 | 90.3 | | | 0.043 46 | 1.154 | 53.0 | | |
| Impurity Ⅳ | 0.041 30 | 0 | 0.042 38 | 102.7 | 103.4 | 5.9 | 0 | 0.041 30 | 100.0 | 102.2 | 2.0 |
| 0.041 30 | 0 | 0.045 41 | 110.0 | | | 0 | 0.042 36 | 102.6 | | |
| 0.041 30 | 0 | 0.040 38 | 97.8 | | | 0 | 0.042 99 | 104.1 | | |
| 1.032 | 0 | 1.096 | 106.2 | 105.1 | 0.94 | 0 | 1.108 | 107.4 | 107.4 | 0.14 |
| 1.032 | 0 | 1.078 | 104.5 | | | 0 | 1.110 | 107.5 | | |
| 1.032 | 0 | 1.079 | 104.5 | | | 0 | 1.106 | 107.2 | | |
| 2.064 | 0 | 2.050 | 99.3 | 100.1 | 0.74 | 0 | 2.119 | 102.7 | 102.2 | 0.65 |
| 2.064 | 0 | 2.067 | 100.2 | | | 0 | 2.117 | 102.6 | | |
| 2.064 | 0 | 2.081 | 100.8 | | | 0 | 2.094 | 101.5 | | |
| Impurity Ⅴ | 0.219 3 | 0.419 4 | 0.654 4 | 107.2 | 108.6 | 1.9 | 0.082 08 | 0.307 7 | 102.9 | 103.3 | 0.70 |
| 0.219 3 | 0.419 4 | 0.655 5 | 107.7 | | | 0.082 08 | 0.307 8 | 102.9 | | |
| 0.219 3 | 0.419 4 | 0.662 8 | 111.0 | | | 0.082 08 | 0.310 5 | 104.2 | | |
| 1.096 | 0.419 4 | 1.611 | 108.6 | 108.0 | 0.88 | 0.082 08 | 1.233 | 104.9 | 104.6 | 0.32 |
| 1.096 | 0.419 4 | 1.593 | 106.9 | | | 0.082 08 | 1.226 | 104.3 | | |
| 1.096 | 0.419 4 | 1.611 | 108.6 | | | 0.082 08 | 1.228 | 104.5 | | |
| 2.193 | 0.419 4 | 2.635 | 102.1 | 102.0 | 0.63 | 0.082 08 | 2.281 | 100.5 | 100.5 | 0.02 |
| 2.193 | 0.419 4 | 2.616 | 101.2 | | | 0.082 08 | 2.281 | 100.5 | | |
| 2.193 | 0.419 4 | 2.643 | 102.5 | | | 0.082 08 | 2.282 | 100.5 | | |
| Impurity Ⅵ | 0.427 0 | 0 | 0.790 5 | 105.9 | 106.2 | 0.88 | 0 | 0.878 1 | 109.4 | 109.3 | 0.34 |
| 0.427 0 | 0 | 0.796 5 | 107.3 | | | 0 | 0.875 6 | 108.8 | | |
| 0.427 0 | 0 | 0.788 9 | 105.5 | | | 0 | 0.878 5 | 109.5 | | |
| 1.068 | 0 | 1.537 | 113.6 | 107.4 | 5.2 | 0 | 1.513 | 104.9 | 104.9 | 0.43 |
| 1.068 | 0 | 1.449 | 105.4 | | | 0 | 1.508 | 104.4 | | |
| 1.068 | 0 | 1.424 | 103.0 | | | 0 | 1.518 | 105.3 | | |
| 2.135 | 0 | 2.460 | 101.3 | 100.5 | 1.4 | 0 | 2.606 | 105.2 | 105.1 | 0.60 |
| 2.135 | 0 | 2.409 | 98.9 | | | 0 | 2.619 | 105.8 | | |
| 2.135 | 0 | 2.461 | 101.3 | | | 0 | 2.592 | 104.5 | | |
| Impurity Ⅶ | 0.193 2 | 0 | 0.198 5 | 102.7 | 104.0 | 1.7 | 0 | 0.208 9 | 108.1 | 107.3 | 0.95 |
| 0.193 2 | 0 | 0.204 9 | 106.1 | | | 0 | 0.205 1 | 106.2 | | |
| 0.193 2 | 0 | 0.199 5 | 103.3 | | | 0 | 0.208 0 | 107.6 | | |
| 0.965 9 | 0 | 0.992 1 | 102.7 | 104.3 | 1.7 | 0 | 1.008 6 | 104.4 | 104.1 | 0.66 |
| 0.965 9 | 0 | 1.003 | 103.8 | | | 0 | 0.998 | 103.3 | | |
| 0.965 9 | 0 | 1.026 | 106.2 | | | 0 | 1.011 | 104.6 | | |
| 1.932 | 0 | 1.945 | 100.7 | 100.7 | 0.46 | 0 | 1.964 | 101.7 | 101.4 | 0.38 |
| 1.932 | 0 | 1.956 | 101.2 | | | 0 | 1.950 | 100.9 | | |
| 1.932 | 0 | 1.938 | 100.3 | | | 0 | 1.961 | 101.5 | | |
| Impurity Ⅷ | 0.211 3 | 0.086 62 | 0.296 5 | 104.6 | 103.1 | 1.3 | 0.100 4 | 0.324 0 | 105.8 | 106.1 | 0.27 |
| 0.211 3 | 0.086 62 | 0.292 2 | 102.5 | | | 0.100 4 | 0.325 2 | 106.4 | | |
| 0.211 3 | 0.086 62 | 0.291 4 | 102.2 | | | 0.100 4 | 0.324 2 | 105.9 | | |
| 1.057 | 0.086 62 | 1.185 | 105.0 | 105.2 | 0.46 | 0.100 4 | 1.213 | 105.2 | 104.9 | 0.32 |
| 1.057 | 0.086 62 | 1.194 | 105.8 | | | 0.100 4 | 1.208 | 104.8 | | |
| 1.057 | 0.086 62 | 1.184 | 104.9 | | | 0.100 4 | 1.206 | 104.6 | | |
| 2.113 | 0.086 62 | 2.213 | 101.3 | 100.0 | 1.2 | 0.100 4 | 2.254 | 102.2 | 102.1 | 0.10 |
| 2.113 | 0.086 62 | 2.164 | 99.0 | | | 0.100 4 | 2.250 | 102.0 | | |
| 2.113 | 0.086 62 | 2.179 | 99.7 | | | 0.100 4 | 2.253 | 102.1 | | |
| Impurity Ⅸ | 0.102 3 | 0 | 0.094 77 | 92.6 | 96.6 | 3.59 | 0 | 0.101 7 | 99.4 | 100.9 | 1.6 |
| 0.102 3 | 0 | 0.101 0 | 98.8 | | | 0 | 0.102 9 | 100.6 | | |
| 0.102 3 | 0 | 0.100 8 | 98.5 | | | 0 | 0.105 0 | 102.7 | | |
| 1.023 | 0 | 1.074 | 105.0 | 104.9 | 0.85 | 0 | 1.081 | 105.7 | 105.9 | 0.30 |
| 1.023 | 0 | 1.082 | 105.7 | | | 0 | 1.082 | 105.8 | | |
| 1.023 | 0 | 1.063 | 104.0 | | | 0 | 1.087 | 106.3 | | |
| 2.046 | 0 | 2.055 | 100.4 | 100.1 | 0.27 | 0 | 2.061 | 100.8 | 100.9 | 0.13 |
| 2.046 | 0 | 2.046 | 100.0 | | | 0 | 2.063 | 100.8 | | |
| 2.046 | 0 | 2.045 | 99.9 | | | 0 | 2.066 | 101.0 | | |
| Impurity Ⅹ | 0.414 3 | 0.483 9 | 0.910 0 | 102.9 | 105.8 | 2.4 | 0 | 0.442 6 | 106.8 | 107.0 | 0.15 |
| 0.414 3 | 0.483 9 | 0.929 1 | 107.5 | | | 0 | 0.443 9 | 107.1 | | |
| 0.414 3 | 0.483 9 | 0.927 0 | 107.0 | | | 0 | 0.443 2 | 107.0 | | |
| 1.036 | 0.483 9 | 1.549 | 103. 9 | 106.1 | 2.0 | 0 | 1.099 | 106.1 | 106.1 | 0.18 |
| 1.036 | 0.483 9 | 1.574 | 106.3 | | | 0 | 1.096 | 105.8 | | |
| 1.036 | 0.483 9 | 1.594 | 108.2 | | | 0 | 1.100 | 106.2 | | |
| 2.072 | 0.483 9 | 2.475 | 97. 8 | 99.2 | 1.4 | 0 | 2.100 | 101.4 | 101.4 | 0.14 |
| 2.072 | 0.483 9 | 2.502 | 99.1 | | | 0 | 2.097 | 101.2 | | |
| 2.072 | 0.483 9 | 2.533 | 100.6 | | | 0 | 2.103 | 101.5 | | |
| Impurity Ⅺ | 1.026 | 0 | 1.023 | 99.7 | 103.0 | 3.3 | 0 | 1.070 | 104.4 | 104.7 | 1.1 |
| 1.026 | 0 | 1.092 | 106.5 | | | 0 | 1.087 | 106.0 | | |
| 1.026 | 0 | 1.056 | 102.9 | | | 0 | 1.065 | 103.9 | | |
| 1.026 | 0 | 0.990 2 | 96.5 | 98.3 | 1.7 | 0 | 1.053 | 102.6 | 103.1 | 0.50 |
| 1.026 | 0 | 1.009 | 98.4 | | | 0 | 1.063 | 103.7 | | |
| 1.026 | 0 | 1.025 | 100.0 | | | 0 | 1.057 | 103.1 | | |
| 2.051 | 0 | 2.001 | 97. 6 | 97.3 | 0.87 | 0 | 2.057 | 100.3 | 100.5 | 0.53 |
| 2.051 | 0 | 2.008 | 97. 9 | | | 0 | 2.054 | 100.1 | | |
| 2.051 | 0 | 1.975 | 96.3 | | | 0 | 2.075 | 101.1 | | |
| Impurity Ⅻ | 0.421 3 | 0 | 0.443 9 | 105.4 | 104.8 | 1.3 | 0 | 0.439 7 | 104.4 | 104.3 | 0.31 |
| 0.421 3 | 0 | 0.445 7 | 105.8 | | | 0 | 0.440 6 | 104.6 | | |
| 0.421 3 | 0 | 0.435 3 | 103.3 | | | 0 | 0.437 9 | 103.9 | | |
| 1.053 | 0 | 1.074 | 102.0 | 106.0 | 3.5 | 0 | 1.094 | 103.9 | 104.1 | 0.57 |
| 1.053 | 0 | 1.126 | 106.9 | | | 0 | 1.103 | 104.7 | | |
| 1.053 | 0 | 1.151 | 109.3 | | | 0 | 1.091 | 103.6 | | |
| 2.106 | 0 | 2.053 | 97.5 | 98.5 | 0.91 | 0 | 2.242 | 106.4 | 106.0 | 0.54 |
| 2.106 | 0 | 2.082 | 98.8 | | | 0 | 2.219 | 105.3 | | |
| 2.106 | 0 | 2.089 | 99. 2 | | | 0 | 2.236 | 106.1 | | |
| Impurity B | 0.102 7 | 0.495 2 | 0.594 9 | 97.0 | 96.9 | 2.1 | 0.706 2 | 0.811 3 | 102.3 | 107.2 | 4.0 |
| 0.102 7 | 0.495 2 | 0.592 4 | 94.7 | | | 0.706 2 | 0.819 1 | 109.9 | | |
| 0.102 7 | 0.495 2 | 0.596 7 | 98.8 | | | 0.706 2 | 0.818 6 | 109.4 | | |
| 1.027 | 0.495 2 | 1.553 | 102.5 | 103.0 | 0.79 | 0.706 2 | 1.799 | 105.7 | 106.5 | 1.3 |
| 1.027 | 0.495 2 | 1.568 | 104.0 | | | 0.706 2 | 1.799 | 105.7 | | |
| 1.027 | 0.495 2 | 1.554 | 102.6 | | | 0.706 2 | 1.825 | 108.2 | | |
| 2.053 | 0.495 2 | 2.489 | 98.2 | 98.9 | 0.63 | 0.706 2 | 2.782 | 102.6 | 102.6 | 0.14 |
| 2.053 | 0.495 2 | 2.510 | 99. 2 | | | 0.706 2 | 2.778 | 102.4 | | |
| 2.053 | 0.495 2 | 2.513 | 99.3 | | | 0.706 2 | 2.784 | 102.7 | | |
| Impurity ⅩⅢ | 0.104 4 | 0 | 0.117 3 | 112.3 | 104.2 | 7.0 | 0 | 0.111 5 | 106.8 | 107.1 | 1.1 |
| 0.104 4 | 0 | 0.102 5 | 98.1 | | | 0 | 0.113 1 | 108.3 | | |
| 0.104 4 | 0 | 0.106 5 | 102.0 | | | 0 | 0.110 7 | 106.0 | | |
| 1.044 | 0 | 1.104 | 105.8 | 105.9 | 0.28 | 0 | 1.107 | 106.0 | 106.5 | 0.41 |
| 1.044 | 0 | 1.109 | 106.2 | | | 0 | 1.112 | 106.5 | | |
| 1.044 | 0 | 1.103 | 105. 7 | | | 0 | 1.116 | 106.9 | | |
| 2.088 | 0 | 2.096 | 100.4 | 100.3 | 0.24 | 0 | 2.112 | 101.2 | 101.3 | 0.27 |
| 2.088 | 0 | 2.089 | 100.0 | | | 0 | 2.109 | 101.0 | | |
| 2.088 | 0 | 2.098 | 100.5 | | | 0 | 2.120 | 101.5 | | |
| Impurity ⅩⅣ | 0.107 0 | 0 | 0.102 8 | 96.0 | 96.3 | 0.48 | 0 | 0.100 2 | 93.7 | 93.2 | 0.53 |
| 0.107 0 | 0 | 0.103 6 | 96.9 | | | 0 | 0.099 6 | 93.1 | | |
| 0.107 0 | 0 | 0.102 8 | 96.1 | | | 0 | 0.099 2 | 92.7 | | |
| 1.070 | 0 | 1.124 | 105.0 | 105.3 | 0.36 | 0 | 1.125 | 105.1 | 105.6 | 0.57 |
| 1.070 | 0 | 1.125 | 105.1 | | | 0 | 1.138 | 106.3 | | |
| 1.070 | 0 | 1.132 | 105.7 | | | 0 | 1.129 | 105.5 | | |
| 2.141 | 0 | 2.138 | 99.9 | 100.0 | 0.28 | 0 | 2.172 | 101.5 | 101.2 | 0.23 |
| 2.141 | 0 | 2.138 | 99.9 | | | 0 | 2.165 | 101.1 | | |
| 2.141 | 0 | 2.148 | 100.3 | | | 0 | 2.163 | 101.0 | | |
| Impurity ⅩⅤ | 0.222 1 | 0 | 0.217 2 | 97.8 | 100.6 | 2.8 | 0 | 0.213 4 | 96.1 | 96.4 | 1.3 |
| 0.222 1 | 0 | 0.223 1 | 100.5 | | | 0 | 0.217 3 | 97.9 | | |
| 0.222 1 | 0 | 0.229 7 | 103.4 | | | 0 | 0.211 8 | 95.4 | | |
| 1.111 | 0 | 1.187 | 106.9 | 105.7 | 0.97 | 0 | 1.183 | 106.5 | 106.7 | 0.32 |
| 1.111 | 0 | 1.166 | 104.9 | | | 0 | 1.189 | 107.1 | | |
| 1.111 | 0 | 1.169 | 105.3 | | | 0 | 1.182 | 106.4 | | |
| 2.221 | 0 | 2.248 | 101.2 | 100.8 | 0.66 | 0 | 2.252 | 101.4 | 101.0 | 0.29 |
| 2.221 | 0 | 2.221 | 100.0 | | | 0 | 2.241 | 100.9 | | |
| 2.221 | 0 | 2.245 | 101.1 | | | 0 | 2.240 | 100.8 | | |
| Impurity ⅩⅥ | 0.210 4 | 0 | 0.211 1 | 100.4 | 101.6 | 1.6 | 0 | 0.194 5 | 92.4 | 93.2 | 0.83 |
| 0.210 4 | 0 | 0.212 4 | 101.0 | | | 0 | 0.195 9 | 93.1 | | |
| 0.210 4 | 0 | 0.217 6 | 103.4 | | | 0 | 0.197 8 | 94.0 | | |
| 1.052 | 0 | 1.085 | 103.1 | 102.9 | 0.65 | 0 | 1.013 | 96.3 | 96.0 | 0.34 |
| 1.052 | 0 | 1.089 | 103.5 | | | 0 | 1.007 | 95.7 | | |
| 1.052 | 0 | 1.075 | 102.2 | | | 0 | 1.011 | 96.1 | | |
| 2.104 | 0 | 2.137 | 101.5 | 100.9 | 0.58 | 0 | 1.985 | 94.3 | 94.3 | 0.05 |
| 2.104 | 0 | 2.114 | 100.5 | | | 0 | 1.986 | 94.4 | | |
| 2.104 | 0 | 2.118 | 100.6 | | | 0 | 1.984 | 94.3 | | |
| Impurity ⅩⅦ | 0.439 1 | 0.481 9 | 0.931 7 | 102.4 | 103.6 | 1.9 | 0 | 0.447 1 | 101.8 | 101.9 | 0.39 |
| 0.439 1 | 0.481 9 | 0.946 4 | 105.8 | | | 0 | 0.445 8 | 101.5 | | |
| 0.439 1 | 0.481 9 | 0.931 9 | 102.5 | | | 0 | 0.449 2 | 102.3 | | |
| 1.098 | 0.481 9 | 1.635 | 103.9 | 104.1 | 0.81 | 0 | 1.138 | 103.7 | 104.3 | 0.64 |
| 1.098 | 0.481 9 | 1.629 | 103.3 | | | 0 | 1.152 | 105.0 | | |
| 1.098 | 0.481 9 | 1.647 | 105.0 | | | 0 | 1.143 | 104.1 | | |
| 2.195 | 0.481 9 | 2.640 | 99.1 | 99.9 | 0.91 | 0 | 2.183 | 99.4 | 99.8 | 0.29 |
| 2.195 | 0.481 9 | 2.654 | 99. 8 | | | 0 | 2.195 | 100.0 | | |
| 2.195 | 0.481 9 | 2.679 | 100.9 | | | 0 | 2.193 | 99.9 | | |
), ArticleFig(id=1195498456426004947, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, label=表5, caption=
吉非替尼原料和片剂中各杂质回收率试验结果
, figureFileSmall=null, figureFileBig=null, tableContent=
| Impurities | Gefitinib | Gefitinib tablets |
ρ(Added) /μg·mL-1 | ρ(Original) /μg·mL-1 | ρ(Measured) /μg·mL-1 | Recovery /% | Average /% | RSD /% | ρ(Original) /μg·mL-1 | ρ(Measured) /μg·mL-1 | Recovery /% | Average /% | RSD /% |
| Impurity A | 0.062 50 | 0 | 0.062 23 | 99.6 | 98.5 | 2.1 | 0 | 0.067 68 | 108.3 | 108.0 | 0.35 |
| 0.062 50 | 0 | 0.060 14 | 96.2 | | | 0 | 0.067 50 | 108.0 | | |
| 0.062 50 | 0 | 0.062 41 | 99.9 | | | 0 | 0.067 22 | 107.6 | | |
| 1.042 | 0 | 1.109 | 106.4 | 106.5 | 0.73 | 0 | 1.110 | 106.5 | 106.8 | 0.28 |
| 1.042 | 0 | 1.118 | 107.3 | | | 0 | 1.113 | 106.8 | | |
| 1.042 | 0 | 1.102 | 105.7 | | | 0 | 1.116 | 107.1 | | |
| 2.084 | 0 | 2.089 | 100.2 | 100.6 | 0.46 | 0 | 2.148 | 103.1 | 103.0 | 0.15 |
| 2.084 | 0 | 2.095 | 100.5 | | | 0 | 2.144 | 102.9 | | |
| 2.084 | 0 | 2.107 | 101.1 | | | 0 | 2.150 | 103.2 | | |
| Impurity Ⅲ | 0.105 0 | 0 | 0.102 5 | 97.6 | 94.5 | 5.3 | 0.043 46 | 0.103 2 | 56.9 | 57.2 | 1.29 |
| 0.105 0 | 0 | 0.102 1 | 97.3 | | | 0.043 46 | 0.104 4 | 58.0 | | |
| 0.105 0 | 0 | 0.093 2 | 88.7 | | | 0.043 46 | 0.102 9 | 56.7 | | |
| 1.050 | 0 | 0.938 6 | 89.4 | 89.4 | 0.93 | 0.043 46 | 0.645 4 | 57.4 | 56.8 | 0.86 |
| 1.050 | 0 | 0.947 4 | 90.2 | | | 0.043 46 | 0.636 5 | 56.5 | | |
| 1.050 | 0 | 0.929 9 | 88.6 | | | 0.043 46 | 0.636 6 | 56.5 | | |
| 2.100 | 0 | 1.896 | 90.3 | 90.6 | 0.57 | 0.043 46 | 1.264 | 58.2 | 56.0 | 4.8 |
| 2.100 | 0 | 1.915 | 91.2 | | | 0.043 46 | 1.235 | 56.9 | | |
| 2.100 | 0 | 1.896 | 90.3 | | | 0.043 46 | 1.154 | 53.0 | | |
| Impurity Ⅳ | 0.041 30 | 0 | 0.042 38 | 102.7 | 103.4 | 5.9 | 0 | 0.041 30 | 100.0 | 102.2 | 2.0 |
| 0.041 30 | 0 | 0.045 41 | 110.0 | | | 0 | 0.042 36 | 102.6 | | |
| 0.041 30 | 0 | 0.040 38 | 97.8 | | | 0 | 0.042 99 | 104.1 | | |
| 1.032 | 0 | 1.096 | 106.2 | 105.1 | 0.94 | 0 | 1.108 | 107.4 | 107.4 | 0.14 |
| 1.032 | 0 | 1.078 | 104.5 | | | 0 | 1.110 | 107.5 | | |
| 1.032 | 0 | 1.079 | 104.5 | | | 0 | 1.106 | 107.2 | | |
| 2.064 | 0 | 2.050 | 99.3 | 100.1 | 0.74 | 0 | 2.119 | 102.7 | 102.2 | 0.65 |
| 2.064 | 0 | 2.067 | 100.2 | | | 0 | 2.117 | 102.6 | | |
| 2.064 | 0 | 2.081 | 100.8 | | | 0 | 2.094 | 101.5 | | |
| Impurity Ⅴ | 0.219 3 | 0.419 4 | 0.654 4 | 107.2 | 108.6 | 1.9 | 0.082 08 | 0.307 7 | 102.9 | 103.3 | 0.70 |
| 0.219 3 | 0.419 4 | 0.655 5 | 107.7 | | | 0.082 08 | 0.307 8 | 102.9 | | |
| 0.219 3 | 0.419 4 | 0.662 8 | 111.0 | | | 0.082 08 | 0.310 5 | 104.2 | | |
| 1.096 | 0.419 4 | 1.611 | 108.6 | 108.0 | 0.88 | 0.082 08 | 1.233 | 104.9 | 104.6 | 0.32 |
| 1.096 | 0.419 4 | 1.593 | 106.9 | | | 0.082 08 | 1.226 | 104.3 | | |
| 1.096 | 0.419 4 | 1.611 | 108.6 | | | 0.082 08 | 1.228 | 104.5 | | |
| 2.193 | 0.419 4 | 2.635 | 102.1 | 102.0 | 0.63 | 0.082 08 | 2.281 | 100.5 | 100.5 | 0.02 |
| 2.193 | 0.419 4 | 2.616 | 101.2 | | | 0.082 08 | 2.281 | 100.5 | | |
| 2.193 | 0.419 4 | 2.643 | 102.5 | | | 0.082 08 | 2.282 | 100.5 | | |
| Impurity Ⅵ | 0.427 0 | 0 | 0.790 5 | 105.9 | 106.2 | 0.88 | 0 | 0.878 1 | 109.4 | 109.3 | 0.34 |
| 0.427 0 | 0 | 0.796 5 | 107.3 | | | 0 | 0.875 6 | 108.8 | | |
| 0.427 0 | 0 | 0.788 9 | 105.5 | | | 0 | 0.878 5 | 109.5 | | |
| 1.068 | 0 | 1.537 | 113.6 | 107.4 | 5.2 | 0 | 1.513 | 104.9 | 104.9 | 0.43 |
| 1.068 | 0 | 1.449 | 105.4 | | | 0 | 1.508 | 104.4 | | |
| 1.068 | 0 | 1.424 | 103.0 | | | 0 | 1.518 | 105.3 | | |
| 2.135 | 0 | 2.460 | 101.3 | 100.5 | 1.4 | 0 | 2.606 | 105.2 | 105.1 | 0.60 |
| 2.135 | 0 | 2.409 | 98.9 | | | 0 | 2.619 | 105.8 | | |
| 2.135 | 0 | 2.461 | 101.3 | | | 0 | 2.592 | 104.5 | | |
| Impurity Ⅶ | 0.193 2 | 0 | 0.198 5 | 102.7 | 104.0 | 1.7 | 0 | 0.208 9 | 108.1 | 107.3 | 0.95 |
| 0.193 2 | 0 | 0.204 9 | 106.1 | | | 0 | 0.205 1 | 106.2 | | |
| 0.193 2 | 0 | 0.199 5 | 103.3 | | | 0 | 0.208 0 | 107.6 | | |
| 0.965 9 | 0 | 0.992 1 | 102.7 | 104.3 | 1.7 | 0 | 1.008 6 | 104.4 | 104.1 | 0.66 |
| 0.965 9 | 0 | 1.003 | 103.8 | | | 0 | 0.998 | 103.3 | | |
| 0.965 9 | 0 | 1.026 | 106.2 | | | 0 | 1.011 | 104.6 | | |
| 1.932 | 0 | 1.945 | 100.7 | 100.7 | 0.46 | 0 | 1.964 | 101.7 | 101.4 | 0.38 |
| 1.932 | 0 | 1.956 | 101.2 | | | 0 | 1.950 | 100.9 | | |
| 1.932 | 0 | 1.938 | 100.3 | | | 0 | 1.961 | 101.5 | | |
| Impurity Ⅷ | 0.211 3 | 0.086 62 | 0.296 5 | 104.6 | 103.1 | 1.3 | 0.100 4 | 0.324 0 | 105.8 | 106.1 | 0.27 |
| 0.211 3 | 0.086 62 | 0.292 2 | 102.5 | | | 0.100 4 | 0.325 2 | 106.4 | | |
| 0.211 3 | 0.086 62 | 0.291 4 | 102.2 | | | 0.100 4 | 0.324 2 | 105.9 | | |
| 1.057 | 0.086 62 | 1.185 | 105.0 | 105.2 | 0.46 | 0.100 4 | 1.213 | 105.2 | 104.9 | 0.32 |
| 1.057 | 0.086 62 | 1.194 | 105.8 | | | 0.100 4 | 1.208 | 104.8 | | |
| 1.057 | 0.086 62 | 1.184 | 104.9 | | | 0.100 4 | 1.206 | 104.6 | | |
| 2.113 | 0.086 62 | 2.213 | 101.3 | 100.0 | 1.2 | 0.100 4 | 2.254 | 102.2 | 102.1 | 0.10 |
| 2.113 | 0.086 62 | 2.164 | 99.0 | | | 0.100 4 | 2.250 | 102.0 | | |
| 2.113 | 0.086 62 | 2.179 | 99.7 | | | 0.100 4 | 2.253 | 102.1 | | |
| Impurity Ⅸ | 0.102 3 | 0 | 0.094 77 | 92.6 | 96.6 | 3.59 | 0 | 0.101 7 | 99.4 | 100.9 | 1.6 |
| 0.102 3 | 0 | 0.101 0 | 98.8 | | | 0 | 0.102 9 | 100.6 | | |
| 0.102 3 | 0 | 0.100 8 | 98.5 | | | 0 | 0.105 0 | 102.7 | | |
| 1.023 | 0 | 1.074 | 105.0 | 104.9 | 0.85 | 0 | 1.081 | 105.7 | 105.9 | 0.30 |
| 1.023 | 0 | 1.082 | 105.7 | | | 0 | 1.082 | 105.8 | | |
| 1.023 | 0 | 1.063 | 104.0 | | | 0 | 1.087 | 106.3 | | |
| 2.046 | 0 | 2.055 | 100.4 | 100.1 | 0.27 | 0 | 2.061 | 100.8 | 100.9 | 0.13 |
| 2.046 | 0 | 2.046 | 100.0 | | | 0 | 2.063 | 100.8 | | |
| 2.046 | 0 | 2.045 | 99.9 | | | 0 | 2.066 | 101.0 | | |
| Impurity Ⅹ | 0.414 3 | 0.483 9 | 0.910 0 | 102.9 | 105.8 | 2.4 | 0 | 0.442 6 | 106.8 | 107.0 | 0.15 |
| 0.414 3 | 0.483 9 | 0.929 1 | 107.5 | | | 0 | 0.443 9 | 107.1 | | |
| 0.414 3 | 0.483 9 | 0.927 0 | 107.0 | | | 0 | 0.443 2 | 107.0 | | |
| 1.036 | 0.483 9 | 1.549 | 103. 9 | 106.1 | 2.0 | 0 | 1.099 | 106.1 | 106.1 | 0.18 |
| 1.036 | 0.483 9 | 1.574 | 106.3 | | | 0 | 1.096 | 105.8 | | |
| 1.036 | 0.483 9 | 1.594 | 108.2 | | | 0 | 1.100 | 106.2 | | |
| 2.072 | 0.483 9 | 2.475 | 97. 8 | 99.2 | 1.4 | 0 | 2.100 | 101.4 | 101.4 | 0.14 |
| 2.072 | 0.483 9 | 2.502 | 99.1 | | | 0 | 2.097 | 101.2 | | |
| 2.072 | 0.483 9 | 2.533 | 100.6 | | | 0 | 2.103 | 101.5 | | |
| Impurity Ⅺ | 1.026 | 0 | 1.023 | 99.7 | 103.0 | 3.3 | 0 | 1.070 | 104.4 | 104.7 | 1.1 |
| 1.026 | 0 | 1.092 | 106.5 | | | 0 | 1.087 | 106.0 | | |
| 1.026 | 0 | 1.056 | 102.9 | | | 0 | 1.065 | 103.9 | | |
| 1.026 | 0 | 0.990 2 | 96.5 | 98.3 | 1.7 | 0 | 1.053 | 102.6 | 103.1 | 0.50 |
| 1.026 | 0 | 1.009 | 98.4 | | | 0 | 1.063 | 103.7 | | |
| 1.026 | 0 | 1.025 | 100.0 | | | 0 | 1.057 | 103.1 | | |
| 2.051 | 0 | 2.001 | 97. 6 | 97.3 | 0.87 | 0 | 2.057 | 100.3 | 100.5 | 0.53 |
| 2.051 | 0 | 2.008 | 97. 9 | | | 0 | 2.054 | 100.1 | | |
| 2.051 | 0 | 1.975 | 96.3 | | | 0 | 2.075 | 101.1 | | |
| Impurity Ⅻ | 0.421 3 | 0 | 0.443 9 | 105.4 | 104.8 | 1.3 | 0 | 0.439 7 | 104.4 | 104.3 | 0.31 |
| 0.421 3 | 0 | 0.445 7 | 105.8 | | | 0 | 0.440 6 | 104.6 | | |
| 0.421 3 | 0 | 0.435 3 | 103.3 | | | 0 | 0.437 9 | 103.9 | | |
| 1.053 | 0 | 1.074 | 102.0 | 106.0 | 3.5 | 0 | 1.094 | 103.9 | 104.1 | 0.57 |
| 1.053 | 0 | 1.126 | 106.9 | | | 0 | 1.103 | 104.7 | | |
| 1.053 | 0 | 1.151 | 109.3 | | | 0 | 1.091 | 103.6 | | |
| 2.106 | 0 | 2.053 | 97.5 | 98.5 | 0.91 | 0 | 2.242 | 106.4 | 106.0 | 0.54 |
| 2.106 | 0 | 2.082 | 98.8 | | | 0 | 2.219 | 105.3 | | |
| 2.106 | 0 | 2.089 | 99. 2 | | | 0 | 2.236 | 106.1 | | |
| Impurity B | 0.102 7 | 0.495 2 | 0.594 9 | 97.0 | 96.9 | 2.1 | 0.706 2 | 0.811 3 | 102.3 | 107.2 | 4.0 |
| 0.102 7 | 0.495 2 | 0.592 4 | 94.7 | | | 0.706 2 | 0.819 1 | 109.9 | | |
| 0.102 7 | 0.495 2 | 0.596 7 | 98.8 | | | 0.706 2 | 0.818 6 | 109.4 | | |
| 1.027 | 0.495 2 | 1.553 | 102.5 | 103.0 | 0.79 | 0.706 2 | 1.799 | 105.7 | 106.5 | 1.3 |
| 1.027 | 0.495 2 | 1.568 | 104.0 | | | 0.706 2 | 1.799 | 105.7 | | |
| 1.027 | 0.495 2 | 1.554 | 102.6 | | | 0.706 2 | 1.825 | 108.2 | | |
| 2.053 | 0.495 2 | 2.489 | 98.2 | 98.9 | 0.63 | 0.706 2 | 2.782 | 102.6 | 102.6 | 0.14 |
| 2.053 | 0.495 2 | 2.510 | 99. 2 | | | 0.706 2 | 2.778 | 102.4 | | |
| 2.053 | 0.495 2 | 2.513 | 99.3 | | | 0.706 2 | 2.784 | 102.7 | | |
| Impurity ⅩⅢ | 0.104 4 | 0 | 0.117 3 | 112.3 | 104.2 | 7.0 | 0 | 0.111 5 | 106.8 | 107.1 | 1.1 |
| 0.104 4 | 0 | 0.102 5 | 98.1 | | | 0 | 0.113 1 | 108.3 | | |
| 0.104 4 | 0 | 0.106 5 | 102.0 | | | 0 | 0.110 7 | 106.0 | | |
| 1.044 | 0 | 1.104 | 105.8 | 105.9 | 0.28 | 0 | 1.107 | 106.0 | 106.5 | 0.41 |
| 1.044 | 0 | 1.109 | 106.2 | | | 0 | 1.112 | 106.5 | | |
| 1.044 | 0 | 1.103 | 105. 7 | | | 0 | 1.116 | 106.9 | | |
| 2.088 | 0 | 2.096 | 100.4 | 100.3 | 0.24 | 0 | 2.112 | 101.2 | 101.3 | 0.27 |
| 2.088 | 0 | 2.089 | 100.0 | | | 0 | 2.109 | 101.0 | | |
| 2.088 | 0 | 2.098 | 100.5 | | | 0 | 2.120 | 101.5 | | |
| Impurity ⅩⅣ | 0.107 0 | 0 | 0.102 8 | 96.0 | 96.3 | 0.48 | 0 | 0.100 2 | 93.7 | 93.2 | 0.53 |
| 0.107 0 | 0 | 0.103 6 | 96.9 | | | 0 | 0.099 6 | 93.1 | | |
| 0.107 0 | 0 | 0.102 8 | 96.1 | | | 0 | 0.099 2 | 92.7 | | |
| 1.070 | 0 | 1.124 | 105.0 | 105.3 | 0.36 | 0 | 1.125 | 105.1 | 105.6 | 0.57 |
| 1.070 | 0 | 1.125 | 105.1 | | | 0 | 1.138 | 106.3 | | |
| 1.070 | 0 | 1.132 | 105.7 | | | 0 | 1.129 | 105.5 | | |
| 2.141 | 0 | 2.138 | 99.9 | 100.0 | 0.28 | 0 | 2.172 | 101.5 | 101.2 | 0.23 |
| 2.141 | 0 | 2.138 | 99.9 | | | 0 | 2.165 | 101.1 | | |
| 2.141 | 0 | 2.148 | 100.3 | | | 0 | 2.163 | 101.0 | | |
| Impurity ⅩⅤ | 0.222 1 | 0 | 0.217 2 | 97.8 | 100.6 | 2.8 | 0 | 0.213 4 | 96.1 | 96.4 | 1.3 |
| 0.222 1 | 0 | 0.223 1 | 100.5 | | | 0 | 0.217 3 | 97.9 | | |
| 0.222 1 | 0 | 0.229 7 | 103.4 | | | 0 | 0.211 8 | 95.4 | | |
| 1.111 | 0 | 1.187 | 106.9 | 105.7 | 0.97 | 0 | 1.183 | 106.5 | 106.7 | 0.32 |
| 1.111 | 0 | 1.166 | 104.9 | | | 0 | 1.189 | 107.1 | | |
| 1.111 | 0 | 1.169 | 105.3 | | | 0 | 1.182 | 106.4 | | |
| 2.221 | 0 | 2.248 | 101.2 | 100.8 | 0.66 | 0 | 2.252 | 101.4 | 101.0 | 0.29 |
| 2.221 | 0 | 2.221 | 100.0 | | | 0 | 2.241 | 100.9 | | |
| 2.221 | 0 | 2.245 | 101.1 | | | 0 | 2.240 | 100.8 | | |
| Impurity ⅩⅥ | 0.210 4 | 0 | 0.211 1 | 100.4 | 101.6 | 1.6 | 0 | 0.194 5 | 92.4 | 93.2 | 0.83 |
| 0.210 4 | 0 | 0.212 4 | 101.0 | | | 0 | 0.195 9 | 93.1 | | |
| 0.210 4 | 0 | 0.217 6 | 103.4 | | | 0 | 0.197 8 | 94.0 | | |
| 1.052 | 0 | 1.085 | 103.1 | 102.9 | 0.65 | 0 | 1.013 | 96.3 | 96.0 | 0.34 |
| 1.052 | 0 | 1.089 | 103.5 | | | 0 | 1.007 | 95.7 | | |
| 1.052 | 0 | 1.075 | 102.2 | | | 0 | 1.011 | 96.1 | | |
| 2.104 | 0 | 2.137 | 101.5 | 100.9 | 0.58 | 0 | 1.985 | 94.3 | 94.3 | 0.05 |
| 2.104 | 0 | 2.114 | 100.5 | | | 0 | 1.986 | 94.4 | | |
| 2.104 | 0 | 2.118 | 100.6 | | | 0 | 1.984 | 94.3 | | |
| Impurity ⅩⅦ | 0.439 1 | 0.481 9 | 0.931 7 | 102.4 | 103.6 | 1.9 | 0 | 0.447 1 | 101.8 | 101.9 | 0.39 |
| 0.439 1 | 0.481 9 | 0.946 4 | 105.8 | | | 0 | 0.445 8 | 101.5 | | |
| 0.439 1 | 0.481 9 | 0.931 9 | 102.5 | | | 0 | 0.449 2 | 102.3 | | |
| 1.098 | 0.481 9 | 1.635 | 103.9 | 104.1 | 0.81 | 0 | 1.138 | 103.7 | 104.3 | 0.64 |
| 1.098 | 0.481 9 | 1.629 | 103.3 | | | 0 | 1.152 | 105.0 | | |
| 1.098 | 0.481 9 | 1.647 | 105.0 | | | 0 | 1.143 | 104.1 | | |
| 2.195 | 0.481 9 | 2.640 | 99.1 | 99.9 | 0.91 | 0 | 2.183 | 99.4 | 99.8 | 0.29 |
| 2.195 | 0.481 9 | 2.654 | 99. 8 | | | 0 | 2.195 | 100.0 | | |
| 2.195 | 0.481 9 | 2.679 | 100.9 | | | 0 | 2.193 | 99.9 | | |
), ArticleFig(id=1195498456547639764, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, label=Tab.6, caption=
Stability results of gefitinib and gefitinib tablets
, figureFileSmall=null, figureFileBig=null, tableContent=
| Compound | RSD/% |
Standard solution | Gefitinib Sample solution | Gefitinib tablet Sample solution |
| Gefitinib | 1.92 | - | - |
| Impurity A | 1.08 | - | - |
| Impurity Ⅲ | 1.99 | - | - |
| Impurity Ⅳ | 0.95 | - | - |
| Impurity Ⅴ | 0.99 | 3.96 | 0.76 |
| ImpurityⅥ | 0.95 | - | - |
| Impurity Ⅶ | 1.24 | - | - |
| Impurity Ⅷ | 1.21 | 2.84 | - |
| Impurity Ⅸ | 0.83 | 2.67 | - |
| Impurity Ⅹ | 1.02 | - | 1.64 |
| Impurity Ⅺ | 2.77 | - | - |
| Impurity Ⅻ | 2.11 | - | - |
| Impurity B | 2.18 | 3.15 | 1.28 |
| Impurity ⅩⅢ | 0.68 | 1.71 | - |
| Impurity ⅩⅣ | 1.45 | 1.86 | - |
| Impurity ⅩⅤ | 0.90 | - | - |
| Impurity ⅩⅥ | 1.52 | - | - |
| Impurity ⅩⅦ | 1.20 | 2.27 | 1.55 |
), ArticleFig(id=1195498456627331541, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, label=表6, caption=
吉非替尼原料和片剂中有关物质测定稳定性试验结果
, figureFileSmall=null, figureFileBig=null, tableContent=
| Compound | RSD/% |
Standard solution | Gefitinib Sample solution | Gefitinib tablet Sample solution |
| Gefitinib | 1.92 | - | - |
| Impurity A | 1.08 | - | - |
| Impurity Ⅲ | 1.99 | - | - |
| Impurity Ⅳ | 0.95 | - | - |
| Impurity Ⅴ | 0.99 | 3.96 | 0.76 |
| ImpurityⅥ | 0.95 | - | - |
| Impurity Ⅶ | 1.24 | - | - |
| Impurity Ⅷ | 1.21 | 2.84 | - |
| Impurity Ⅸ | 0.83 | 2.67 | - |
| Impurity Ⅹ | 1.02 | - | 1.64 |
| Impurity Ⅺ | 2.77 | - | - |
| Impurity Ⅻ | 2.11 | - | - |
| Impurity B | 2.18 | 3.15 | 1.28 |
| Impurity ⅩⅢ | 0.68 | 1.71 | - |
| Impurity ⅩⅣ | 1.45 | 1.86 | - |
| Impurity ⅩⅤ | 0.90 | - | - |
| Impurity ⅩⅥ | 1.52 | - | - |
| Impurity ⅩⅦ | 1.20 | 2.27 | 1.55 |
), ArticleFig(id=1195498456707023318, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, label=Tab.7, caption=
Durability parameters of gefitinib related substances
, figureFileSmall=null, figureFileBig=null, tableContent=
| Variable | Parameters |
| Initial parameters | Instrument:Agilent 1260 Infinity Ⅱ Column:Kromasil(0.46 mm×250 mm,5 μm) Mobile phase A:1% ammonium acetate solution, pH 6.2; Mobile phase B:acetonitrile; Column temperature:30 ℃; Flow rate:1.0 ml·min-1; |
| Column | Welch Ultimate(0.46 mm×250 mm,5 μm) Waters Xbridge(0.46 mm×250 mm,5 μm) Dikma Diamonsil Plus(0.46 mm×250 mm,5 μm) Shimadzu ShimNex CS(0.46 mm×250 mm,5 μm) Dikma Diamonsil C18(2)(0.46 mm×250 mm,5 μm) CAPCELL PAK MGⅡ(0.46 mm×250 mm,5 μm) Waters SunFire(0.46 mm×250 mm,5 μm) TechMate ST(0.46 mm×250 mm,5μm) Waters XSelect HSS(0.46 mm×250 mm,5 μm) Phenomenex Gemini(0.46 mm×250 mm,5 μm) |
| Instrument | Agilent 1260 Infinity |
| Column temperature | 28 ℃ |
| 32 ℃ |
| pH | 6.1 |
| 6.3 |
), ArticleFig(id=1195498456799298007, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, label=表7, caption=
吉非替尼有关物质测定耐用性考察条件
, figureFileSmall=null, figureFileBig=null, tableContent=
| Variable | Parameters |
| Initial parameters | Instrument:Agilent 1260 Infinity Ⅱ Column:Kromasil(0.46 mm×250 mm,5 μm) Mobile phase A:1% ammonium acetate solution, pH 6.2; Mobile phase B:acetonitrile; Column temperature:30 ℃; Flow rate:1.0 ml·min-1; |
| Column | Welch Ultimate(0.46 mm×250 mm,5 μm) Waters Xbridge(0.46 mm×250 mm,5 μm) Dikma Diamonsil Plus(0.46 mm×250 mm,5 μm) Shimadzu ShimNex CS(0.46 mm×250 mm,5 μm) Dikma Diamonsil C18(2)(0.46 mm×250 mm,5 μm) CAPCELL PAK MGⅡ(0.46 mm×250 mm,5 μm) Waters SunFire(0.46 mm×250 mm,5 μm) TechMate ST(0.46 mm×250 mm,5μm) Waters XSelect HSS(0.46 mm×250 mm,5 μm) Phenomenex Gemini(0.46 mm×250 mm,5 μm) |
| Instrument | Agilent 1260 Infinity |
| Column temperature | 28 ℃ |
| 32 ℃ |
| pH | 6.1 |
| 6.3 |
), ArticleFig(id=1195498456878989784, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, label=Tab.8, caption=
Results of related substances of gefitinib
, figureFileSmall=null, figureFileBig=null, tableContent=
| Lot. | Impurity Ⅴ/% | Impurity Ⅷ/% | Impurity Ⅸ/% | Impurity Ⅹ/% | Impurity B/% | Impurity ⅩⅢ/% | Impurity ⅩⅣ/% | Impurity ⅩⅤ/% | Impurity ⅩⅦ/% | Maximum unknown impurity/% | Total /% |
| DA203M-4-181201 | 0.02 | ND | ND | 0.02 | 0.02 | ND | ND | ND | 0.01 | 0.01 | 0.09 |
| DA203M-4-181202 | 0.02 | ND | ND | 0.02 | 0.02 | ND | ND | ND | 0.01 | 0.01 | 0.09 |
| DA203M-4-181203 | 0.02 | ND | ND | 0.02 | 0.02 | ND | ND | ND | 0.01 | 0.01 | 0.09 |
| 0038L61N | ND | ND | ND | ND | 0.01 | ND | 0.002 | ND | 0.002 | 0.03 | 0.04 |
| 0039L61N | ND | ND | ND | ND | 0.01 | ND | ND | ND | 0.004 | 0.02 | 0.04 |
| 0040L61N | ND | ND | ND | ND | 0.01 | ND | 0.002 | ND | 0.006 | 0.02 | 0.05 |
| E02200701 | 0.01 | ND | ND | ND | 0.01 | ND | ND | ND | 0.02 | ND | 0.04 |
| E02200702 | ND | ND | ND | ND | 0.02 | ND | ND | ND | 0.02 | 0.01 | 0.05 |
| E02200801 | ND | ND | ND | ND | 0.01 | ND | ND | ND | 0.01 | 0.01 | 0.03 |
| GEA2009001 | ND | ND | ND | ND | ND | ND | ND | 0.002 | ND | ND | 0.002 |
| GEA2009002 | ND | ND | ND | ND | ND | ND | ND | 0.005 | ND | 0.03 | 0.04 |
| 20190301 | ND | 0.02 | ND | ND | 0.01 | ND | ND | ND | 0.01 | 0.02 | 0.08 |
| 20201201 | ND | 0.01 | ND | ND | 0.01 | ND | ND | ND | ND | 0.02 | 0.08 |
| 20201202 | ND | 0.01 | ND | ND | 0.01 | ND | ND | ND | ND | 0.02 | 0.08 |
| 8220024 | ND | ND | ND | ND | ND | ND | ND | ND | ND | 0.01 | 0.01 |
| 8220025 | ND | ND | ND | ND | ND | ND | ND | ND | ND | 0.02 | 0.04 |
| 8220026 | ND | ND | ND | ND | ND | ND | ND | ND | ND | 0.03 | 0.05 |
| 689200801 | ND | ND | ND | 0.01 | 0.03 | ND | ND | ND | ND | 0.02 | 0.07 |
| 689200802 | ND | ND | ND | ND | 0.01 | ND | ND | ND | ND | ND | 0.01 |
| 689200803 | ND | ND | ND | ND | 0.01 | ND | ND | ND | ND | ND | 0.01 |
| 20181001 | 0.01 | 0.01 | 0.01 | ND | 0.01 | 0.02 | 0.03 | ND | ND | 0.01 | 0.09 |
| 20200603 | 0.01 | ND | 0.02 | ND | 0.03 | 0.03 | ND | ND | ND | 0.01 | 0.07 |
| 20200701 | 0.01 | ND | 0.02 | ND | 0.03 | 0.03 | ND | ND | ND | 0.01 | 0.08 |
| 606110231 | ND | ND | ND | ND | 0.03 | ND | ND | ND | ND | 0.01 | 0.04 |
| 606110232 | ND | ND | ND | ND | 0.03 | ND | ND | ND | ND | 0.01 | 0.05 |
| 606110233 | ND | ND | ND | ND | 0.02 | ND | ND | ND | ND | 0.01 | 0.02 |
), ArticleFig(id=1195498456979653081, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, label=表8, caption=
吉非替尼有关物质测定结果
, figureFileSmall=null, figureFileBig=null, tableContent=
| Lot. | Impurity Ⅴ/% | Impurity Ⅷ/% | Impurity Ⅸ/% | Impurity Ⅹ/% | Impurity B/% | Impurity ⅩⅢ/% | Impurity ⅩⅣ/% | Impurity ⅩⅤ/% | Impurity ⅩⅦ/% | Maximum unknown impurity/% | Total /% |
| DA203M-4-181201 | 0.02 | ND | ND | 0.02 | 0.02 | ND | ND | ND | 0.01 | 0.01 | 0.09 |
| DA203M-4-181202 | 0.02 | ND | ND | 0.02 | 0.02 | ND | ND | ND | 0.01 | 0.01 | 0.09 |
| DA203M-4-181203 | 0.02 | ND | ND | 0.02 | 0.02 | ND | ND | ND | 0.01 | 0.01 | 0.09 |
| 0038L61N | ND | ND | ND | ND | 0.01 | ND | 0.002 | ND | 0.002 | 0.03 | 0.04 |
| 0039L61N | ND | ND | ND | ND | 0.01 | ND | ND | ND | 0.004 | 0.02 | 0.04 |
| 0040L61N | ND | ND | ND | ND | 0.01 | ND | 0.002 | ND | 0.006 | 0.02 | 0.05 |
| E02200701 | 0.01 | ND | ND | ND | 0.01 | ND | ND | ND | 0.02 | ND | 0.04 |
| E02200702 | ND | ND | ND | ND | 0.02 | ND | ND | ND | 0.02 | 0.01 | 0.05 |
| E02200801 | ND | ND | ND | ND | 0.01 | ND | ND | ND | 0.01 | 0.01 | 0.03 |
| GEA2009001 | ND | ND | ND | ND | ND | ND | ND | 0.002 | ND | ND | 0.002 |
| GEA2009002 | ND | ND | ND | ND | ND | ND | ND | 0.005 | ND | 0.03 | 0.04 |
| 20190301 | ND | 0.02 | ND | ND | 0.01 | ND | ND | ND | 0.01 | 0.02 | 0.08 |
| 20201201 | ND | 0.01 | ND | ND | 0.01 | ND | ND | ND | ND | 0.02 | 0.08 |
| 20201202 | ND | 0.01 | ND | ND | 0.01 | ND | ND | ND | ND | 0.02 | 0.08 |
| 8220024 | ND | ND | ND | ND | ND | ND | ND | ND | ND | 0.01 | 0.01 |
| 8220025 | ND | ND | ND | ND | ND | ND | ND | ND | ND | 0.02 | 0.04 |
| 8220026 | ND | ND | ND | ND | ND | ND | ND | ND | ND | 0.03 | 0.05 |
| 689200801 | ND | ND | ND | 0.01 | 0.03 | ND | ND | ND | ND | 0.02 | 0.07 |
| 689200802 | ND | ND | ND | ND | 0.01 | ND | ND | ND | ND | ND | 0.01 |
| 689200803 | ND | ND | ND | ND | 0.01 | ND | ND | ND | ND | ND | 0.01 |
| 20181001 | 0.01 | 0.01 | 0.01 | ND | 0.01 | 0.02 | 0.03 | ND | ND | 0.01 | 0.09 |
| 20200603 | 0.01 | ND | 0.02 | ND | 0.03 | 0.03 | ND | ND | ND | 0.01 | 0.07 |
| 20200701 | 0.01 | ND | 0.02 | ND | 0.03 | 0.03 | ND | ND | ND | 0.01 | 0.08 |
| 606110231 | ND | ND | ND | ND | 0.03 | ND | ND | ND | ND | 0.01 | 0.04 |
| 606110232 | ND | ND | ND | ND | 0.03 | ND | ND | ND | ND | 0.01 | 0.05 |
| 606110233 | ND | ND | ND | ND | 0.02 | ND | ND | ND | ND | 0.01 | 0.02 |
), ArticleFig(id=1195498457076122074, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=EN, label=Tab.9, caption=
Results of related substances of gefitinib tablets
, figureFileSmall=null, figureFileBig=null, tableContent=
| Lot. | Impurity Ⅴ/% | Impurity Ⅷ/% | Impurity Ⅸ/% | Impurity Ⅹ/% | Impurity Ⅻ/% | Impurity B/% | Impurity XIII/% | Impurity ⅩⅫ/% | Maximum unknown impurity /% | Total /% | |
| 2031190301 | 0.03 | ND | ND | 0.02 | ND | 0.02 | ND | 0.01 | 0.01 | 0.10 | |
| 2031190302 | 0.03 | ND | ND | 0.02 | ND | 0.02 | ND | 0.01 | 0.01 | 0.10 | |
| 2031190303 | 0.04 | ND | ND | 0.02 | 0.02 | 0.02 | ND | 0.03 | 0.01 | 0.17 | |
| DC1B0149 | 0.01 | ND | ND | ND | ND | 0.02 | ND | ND | 0.01 | 0.05 | |
| DC1B0150 | 0.01 | ND | ND | ND | ND | 0.02 | ND | ND | 0.01 | 0.05 | |
| DC1B0151 | 0.01 | ND | ND | ND | ND | 0.03 | ND | ND | 0.02 | 0.07 | |
| 1R200701 | 0.01 | ND | ND | 0.02 | ND | 0.01 | ND | 0.01 | 0.03 | 0.06 | |
| 20080711 | 0.01 | ND | ND | 0.01 | ND | 0.01 | ND | 0.02 | ND | 0.05 | |
| 20190108 | 0.01 | 0.02 | ND | ND | ND | 0.01 | ND | 0.01 | 0.02 | 0.08 | |
| 20190109 | 0.01 | 0.03 | ND | ND | ND | 0.01 | ND | 0.01 | 0.02 | 0.10 | |
| 20200708 | 0.01 | 0.02 | ND | ND | ND | 0.01 | ND | 0.01 | 0.01 | 0.06 | |
| 200510132 | 0.02 | ND | ND | ND | ND | 0.01 | ND | ND | 0.01 | 0.05 | |
| 200606132 | 0.02 | ND | ND | ND | ND | 0.003 | ND | ND | 0.01 | 0.04 | |
| 200606232 | 0.02 | ND | ND | ND | ND | ND | ND | ND | 0.01 | 0.05 | |
| 20181201 | 0.02 | 0.01 | 0.01 | ND | ND | 0.01 | 0.003 | ND | 0.01 | 0.08 | |
| 20190102 | 0.01 | 0.01 | 0.02 | ND | ND | 0.01 | 0.01 | ND | 0.01 | 0.11 | |
| 20200701 | 0.01 | ND | 0.02 | ND | ND | 0.03 | 0.004 | ND | 0.01 | 0.10 | |
| 2004014 | 0.01 | ND | ND | ND | ND | 0.03 | ND | ND | ND | 0.04 | |
| 2004015 | 0.01 | ND | ND | ND | ND | 0.03 | ND | ND | ND | 0.05 | |
| 2005013 | 0.01 | ND | ND | ND | ND | 0.03 | ND | ND | ND | 0.06 | |
), ArticleFig(id=1195498457172591067, tenantId=1146029695717560320, journalId=1190317699101192196, articleId=1195386782205391084, language=CN, label=表9, caption=
吉非替尼片有关物质测定结果
, figureFileSmall=null, figureFileBig=null, tableContent=
| Lot. | Impurity Ⅴ/% | Impurity Ⅷ/% | Impurity Ⅸ/% | Impurity Ⅹ/% | Impurity Ⅻ/% | Impurity B/% | Impurity XIII/% | Impurity ⅩⅫ/% | Maximum unknown impurity /% | Total /% | |
| 2031190301 | 0.03 | ND | ND | 0.02 | ND | 0.02 | ND | 0.01 | 0.01 | 0.10 | |
| 2031190302 | 0.03 | ND | ND | 0.02 | ND | 0.02 | ND | 0.01 | 0.01 | 0.10 | |
| 2031190303 | 0.04 | ND | ND | 0.02 | 0.02 | 0.02 | ND | 0.03 | 0.01 | 0.17 | |
| DC1B0149 | 0.01 | ND | ND | ND | ND | 0.02 | ND | ND | 0.01 | 0.05 | |
| DC1B0150 | 0.01 | ND | ND | ND | ND | 0.02 | ND | ND | 0.01 | 0.05 | |
| DC1B0151 | 0.01 | ND | ND | ND | ND | 0.03 | ND | ND | 0.02 | 0.07 | |
| 1R200701 | 0.01 | ND | ND | 0.02 | ND | 0.01 | ND | 0.01 | 0.03 | 0.06 | |
| 20080711 | 0.01 | ND | ND | 0.01 | ND | 0.01 | ND | 0.02 | ND | 0.05 | |
| 20190108 | 0.01 | 0.02 | ND | ND | ND | 0.01 | ND | 0.01 | 0.02 | 0.08 | |
| 20190109 | 0.01 | 0.03 | ND | ND | ND | 0.01 | ND | 0.01 | 0.02 | 0.10 | |
| 20200708 | 0.01 | 0.02 | ND | ND | ND | 0.01 | ND | 0.01 | 0.01 | 0.06 | |
| 200510132 | 0.02 | ND | ND | ND | ND | 0.01 | ND | ND | 0.01 | 0.05 | |
| 200606132 | 0.02 | ND | ND | ND | ND | 0.003 | ND | ND | 0.01 | 0.04 | |
| 200606232 | 0.02 | ND | ND | ND | ND | ND | ND | ND | 0.01 | 0.05 | |
| 20181201 | 0.02 | 0.01 | 0.01 | ND | ND | 0.01 | 0.003 | ND | 0.01 | 0.08 | |
| 20190102 | 0.01 | 0.01 | 0.02 | ND | ND | 0.01 | 0.01 | ND | 0.01 | 0.11 | |
| 20200701 | 0.01 | ND | 0.02 | ND | ND | 0.03 | 0.004 | ND | 0.01 | 0.10 | |
| 2004014 | 0.01 | ND | ND | ND | ND | 0.03 | ND | ND | ND | 0.04 | |
| 2004015 | 0.01 | ND | ND | ND | ND | 0.03 | ND | ND | ND | 0.05 | |
| 2005013 | 0.01 | ND | ND | ND | ND | 0.03 | ND | ND | ND | 0.06 | |
)], attaches=null, journal=Journal(id=1190317596361715715, delFlag=0, nameCn=中国药学杂志, nameEn=Chinese Pharmaceutical Journal, nameHistory1=null, nameHistory2=null, issn=1001-2494, eissn=null, cn=11-2162/R, coden=null, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=hRN1R6HnoNwYkve/JRn0DA==, journalPrice=null, startedYear=null, abbrevIsoEn=null, journalRemark=null, publicationField=null, createdTime=1761723430007, updatedTime=1761735858241, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=C, firstLetterEn=C, subjectCode=Life Sciences, subjectName=Life Sciences, subjectCodeEn=Life Sciences, subjectNameEn=null, picCn=hRN1R6HnoNwYkve/JRn0DA==, picEn=xSRntM4yOh2wVIE2w+OjYg==, jcr=null, cjcr=null, exts=[JournalExt(id=1190369724262355196, language=CN, name=中国药学杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1761735858264, updatedTime=1761735858264, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyxzzauthor.manuscriptcloud.com/login, submissionEditorUrl=https://zgyxzzeditor.manuscriptcloud.com/login, submissionReviewUrl=https://zgyxzzauthor.manuscriptcloud.com/login, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1190369724358824189, language=EN, name=Chinese Pharmaceutical Journal, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1761735858287, updatedTime=1761735858287, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyxzzauthor.manuscriptcloud.com/login, submissionEditorUrl=https://zgyxzzeditor.manuscriptcloud.com/login, submissionReviewUrl=https://zgyxzzauthor.manuscriptcloud.com/login, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1190317699101192196, websiteList=[Website(id=1190317834875011552, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1190317699101192196, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyxzz/CN, language=CN, createTime=1761723486870, createBy=18614031015, updateTime=1761723510130, updateBy=18614031015, name=中国药学杂志-中文, tplId=1146099689490845704, title=中国药学杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1190318144041353703, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834875011552, code=articleTextType, value=kx, createTime=1761723560581, updateTime=1761723560581, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318144016187876, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834875011552, code=banner, value=null, createTime=1761723560575, updateTime=1761723560575, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318144062325226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834875011552, code=grayFlag, value=0, createTime=1761723560586, updateTime=1761723560586, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318144007799267, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834875011552, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyxzz/CN/file/pic?fileId=puyAm9wIHqZks7K8hj8APQ==, createTime=1761723560573, updateTime=1761723560573, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318144074908140, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834875011552, code=minRunFlag, value=0, createTime=1761723560589, updateTime=1761723560589, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318144032965094, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834875011552, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyxzz/CN/file/pic, createTime=1761723560579, updateTime=1761723560579, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318144070713835, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834875011552, code=silenceFlag, value=0, createTime=1761723560588, updateTime=1761723560588, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318144024576485, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834875011552, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1761723560577, updateTime=1761723560577, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318144049742312, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834875011552, code=themeColor, value=null, createTime=1761723560583, updateTime=1761723560583, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318144053936617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834875011552, code=themeStyle, value=null, createTime=1761723560584, updateTime=1761723560584, creator=18614031015, updator=18614031015)]), Website(id=1190317834937926113, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1190317699101192196, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyxzz/EN, language=EN, createTime=1761723486885, createBy=18614031015, updateTime=1761723527689, updateBy=18614031015, name=中国药学杂志-英文, tplId=1146101810881728533, title=Chinese Pharmaceutical Journal, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1190318170478051825, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834937926113, code=articleTextType, value=kx, createTime=1761723566884, updateTime=1761723566884, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318170461274606, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834937926113, code=banner, value=null, createTime=1761723566880, updateTime=1761723566880, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318170494829044, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834937926113, code=grayFlag, value=0, createTime=1761723566888, updateTime=1761723566888, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318170452885997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834937926113, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyxzz/EN/file/pic?fileId=puyAm9wIHqZks7K8hj8APQ==, createTime=1761723566878, updateTime=1761723566878, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318170507411958, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834937926113, code=minRunFlag, value=0, createTime=1761723566891, updateTime=1761723566891, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318170473857520, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834937926113, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyxzz/EN/file/pic, createTime=1761723566883, updateTime=1761723566883, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318170503217653, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834937926113, code=silenceFlag, value=0, createTime=1761723566890, updateTime=1761723566890, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318170465468911, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834937926113, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1761723566881, updateTime=1761723566881, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318170482246130, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834937926113, code=themeColor, value=null, createTime=1761723566885, updateTime=1761723566885, creator=18614031015, updator=18614031015), WebsiteProps(id=1190318170486440435, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1190317834937926113, code=themeStyle, value=null, createTime=1761723566886, updateTime=1761723566886, creator=18614031015, updator=18614031015)])], journalTitle=中国药学杂志, weixinUrl=null, journalUrl=http://www.zgyxzz.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Pharmaceutical Journal, journalPhotoCn=hRN1R6HnoNwYkve/JRn0DA==, journalPhotoEn=xSRntM4yOh2wVIE2w+OjYg==, journalFirstLetter=C, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyxzz/CN/10.11669/cpj.2024.01.009, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyxzz/EN/10.11669/cpj.2024.01.009, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyxzz/CN/PDF/10.11669/cpj.2024.01.009, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyxzz/EN/PDF/10.11669/cpj.2024.01.009, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, reference=null)